Publications of Wim Oyen

Accepted or to appear

Papers in international journals

M. Berrevoets, I. Kouijzer, E. Aarntzen, M. Janssen, L. De Geus-Oei, H. Wertheim, B. Kullberg, J. Ten Oever, W. Oyen and C. Bleeker-Rovers. "(18)F-FDG-PET/CT optimizes treatment in Staphylococcus aureus bacteremia and is associated with reduced mortality.". Abstract DOI PMID
I. Desar, P. Braam, S. Kaal, W. Gerritsen, W. Oyen and W. van der Graaf. "Abscopal effect of radiotherapy in a patient with metastatic diffuse-type giant cell tumor.". PDF DOI PMID
T. Meijer, L. de Geus-Oei, E. Visser, W. Oyen, M. Looijen-Salamon, D. Visvikis, A. Verhagen, J. Bussink and D. Vriens. "Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic (18)F Fluorodeoxyglucose PET.". Abstract DOI PMID

2018

Papers in international journals

E. Aarntzen, L. Heijmen and W. Oyen. "18F-FDG PET/CT in Local Ablative Therapies: A Systematic Review", 2018. Abstract DOI PMID
S. Fanti, S. Minozzi, G. Antoch, I. Banks, A. Briganti, I. Carrio, A. Chiti, N. Clarke, M. Eiber, J. De Bono, K. Fizazi, S. Gillessen, S. Gledhill, U. Haberkorn, K. Herrmann, R. Hicks, F. Lecouvet, R. Montironi, P. Ost, J. O'Sullivan, A. Padhani, J. Schalken, H. Scher, B. Tombal, R. van Moorselaar, H. Van Poppel, H. Vargas, J. Walz, W. Weber, H. Wester and W. Oyen. "Consensus on molecular imaging and theranostics in prostate cancer.", 2018. Abstract DOI PMID
M. Hekman, M. Rijpkema, C. Muselaers, E. Oosterwijk, C. de Hulsbergen-Van Kaa, O. Boerman, W. Oyen, J. Langenhuijsen and P. Mulders. "Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study.", 2018. Abstract DOI PMID
M. Hekman, M. Rijpkema, E. Aarntzen, S. Mulder, J. Langenhuijsen, E. Oosterwijk, O. Boerman, W. Oyen and P. Mulders. "Positron Emission Tomography/Computed Tomography with , javax.xml.bind.JAXBElement@51511e9, Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion.", 2018. Abstract DOI PMID
E. de Koster, L. de Geus-Oei, O. Dekkers, I. van Engen-van Grunsven, J. Hamming, E. Corssmit, H. Morreau, A. Schepers, J. Smit, W. Oyen and D. Vriens. "Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid Nodules.", 2018. Abstract DOI PMID
I. Kouijzer, M. Berrevoets, E. Aarntzen, J. de Vries, A. van Dijk, W. Oyen, L. de Geus-Oei and C. Bleeker-Rovers. "18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography as a diagnostic tool in native valve endocarditis", 2018. Abstract DOI PMID
I. Kouijzer, J. van der Meer, W. Oyen and C. Bleeker-Rovers. "Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise.", 2018. DOI PMID
I. Kouijzer, W. Oyen and C. Bleeker-Rovers. "Vascular infection with outside-in vertebral destruction in chronic Q fever.", 2018. DOI PMID
I. Kouijzer, H. Scheper, J. de Rooy, J. Bloem, M. Janssen, L. van den Hoven, A. Hosman, L. Visser, W. Oyen, C. Bleeker-Rovers and L. de Geus-Oei. "The diagnostic value of , javax.xml.bind.JAXBElement@2ea3f20, F-FDG-PET/CT and MRI in suspected vertebral osteomyelitis - a prospective study.", 2018. Abstract DOI PMID
M. Lantinga, R. de Sévaux, T. Gevers, W. Oyen, J. de Fijter, D. Soonawala, R. Zietse, M. Salih, N. Casteleijn, E. Spithoven, E. Meijer, R. Gansevoort and J. Dipak The Of Behalf On Drenth Consortium. "Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease.", 2018. Abstract PMID
D. Lobeek, G. Franssen, M. Ma, H. Wester, C. Decristoforo, W. Oyen, O. Boerman, S. Terry and M. Rijpkema. "In Vivo Characterization of 4 , javax.xml.bind.JAXBElement@27b763e, Ga-Labeled Multimeric RGD Peptides to Image α, javax.xml.bind.JAXBElement@50cab567, β, javax.xml.bind.JAXBElement@bfd9634, Integrin Expression in 2 Human Tumor Xenograft Mouse Models.", 2018. Abstract DOI PMID

2017

Papers in international journals

C. Smids, I. Kouijzer, F. Vos, T. Sprong, A. Hosman, J. de Rooy, E. Aarntzen, L. de Geus-Oei, W. Oyen and C. Bleeker-Rovers. "A comparison of the diagnostic value of MRI and (18)F-FDG-PET/CT in suspected spondylodiscitis.", 2017. Abstract/PDF DOI PMID
S. van den Bosch, T. Dijkema, M. Kunze-Busch, C. Terhaard, C. Raaijmakers, P. Doornaert, F. Hoebers, M. Vergeer, B. Kreike, O. Wijers, W. Oyen and J. Kaanders. "Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.", 2017. Abstract DOI PMID
S. Heskamp, L. Heijmen, D. Gerrits, J. Molkenboer-Kuenen, E. Ter Voert, K. Heinzmann, D. Honess, D. Smith, J. Griffiths, S. Doblas, R. Sinkus, P. Laverman, W. Oyen, A. Heerschap and O. Boerman. "Response Monitoring with [(18)F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases.", 2017. Abstract DOI PMID
I. Hristova, R. Boellaard, P. Galette, L. Shankar, Y. Liu, S. Stroobants, O. Hoekstra and W. Oyen. "Guidelines for quality control of PET/CT scans in a multicenter clinical study.", 2017. Abstract DOI PMID
I. Kouijzer, F. Vos, C. Bleeker-Rovers and W. Oyen. "Clinical application of FDG-PET/CT in metastatic infections.", 2017. Abstract DOI PMID
T. Meijer, L. de Geus-Oei, E. Visser, W. Oyen, M. Looijen-Salamon, D. Visvikis, A. Verhagen, J. Bussink and D. Vriens. "Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic (18)F Fluorodeoxyglucose PET.", 2017. Abstract DOI PMID
E. Usmanij, T. Natroshvili, J. Timmer-Bonte, W. Oyen, M. van der Drift, J. Bussink and L. Geus-Oei. "The Predictive Value of Early In-Treatment (18)F-FDG PET/CT Response to Chemotherapy in Combination with Bevacizumab in Advanced Nonsquamous Non-Small Cell Lung Cancer.", 2017. Abstract DOI PMID

2016

Papers in international journals

C. Muselaers, M. Boers-Sonderen, T. van Oostenbrugge, O. Boerman, I. Desar, A. Stillebroer, S. Mulder, C. van Herpen, J. Langenhuijsen, E. Oosterwijk, W. Oyen and P. Mulders. "Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.", 2016. Abstract/PDF DOI PMID
S. Terry, M. Koenders, G. Franssen, T. Nayak, A. Freimoser-Grundschober, C. Klein, W. Oyen, O. Boerman and P. Laverman. "Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin ?v?3.", 2016. Abstract/PDF DOI PMID
A. Arens, J. Postema, W. Schreurs, A. Lafeber, B. Hendrickx, W. Oyen and W. Vogel. "FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer.", 2016. Abstract DOI PMID
R. de Bree, L. van der Putten, H. van Tinteren, J. Wedman, W. Oyen, L. Janssen, M. van den Brekel, E. Comans, J. Pruim, R. Takes, M. Hobbelink, R. Valdés Olmos, B. van der Laan, M. Boers, O. Hoekstra and C. Leemans. "Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.", 2016. Abstract DOI PMID
W. Grootjans, F. Tixier, C. van der Vos, D. Vriens, C. Le Rest, J. Bussink, W. Oyen, L. de Geus-Oei, D. Visvikis and E. Visser. "The impact of optimal respiratory gating and image noise on evaluation of intra-tumor heterogeneity in 18F-FDG positron emission tomography imaging of lung cancer.", 2016. Abstract/PDF DOI PMID
W. Grootjans, E. Usmanij, W. Oyen, E. van der Heijden, E. Visser, D. Visvikis, M. Hatt, J. Bussink and L. de Geus-Oei. "Performance of automatic image segmentation algorithms for calculating total lesion glycolysis for early response monitoring in non-small cell lung cancer patients during concomitant chemoradiotherapy.", 2016. Abstract DOI PMID
E. Aarntzen, R. Hermsen, J. Drenth, O. Boerman and W. Oyen. "99mTc-CXCL8 SPECT to Monitor Disease Activity in Inflammatory Bowel Disease.", 2016. Abstract DOI PMID
F. Tixier, D. Vriens, C. Cheze-Le Rest, M. Hatt, J. Disselhorst, W. Oyen, L. de Geus-Oei, E. Visser and D. Visvikis. "Comparison of tumor uptake heterogeneity characterization between static and parametric 18F-FDG PET images in Non-Small Cell Lung Cancer.", 2016. Abstract/PDF DOI PMID
K. Bol, E. Aarntzen, J. Pots, M. Olde Nordkamp, M. van de Rakt, N. Scharenborg, A. de Boer, T. van Oorschot, S. Croockewit, W. Blokx, W. Oyen, O. Boerman, R. Mus, M. van Rossum, C. van der Graaf, C. Punt, G. Adema, C. Figdor, I. de Vries and G. Schreibelt. "Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.", 2016. Abstract/PDF DOI PMID
I. Kouijzer, F. Vos, C. Bleeker-Rovers and W. Oyen. "Clinical application of FDG-PET/CT in metastatic infections.", 2016. Abstract PMID
I. Kouijzer, G. Blokhuis, J. Draaisma, W. Oyen, L. de Geus-Oei and C. Bleeker-Rovers. "18F-FDG PET/CT in Detecting Metastatic Infection in Children.", 2016. Abstract/PDF DOI PMID
A. Willemsen, M. Vlenterie, C. van Herpen, N. van Erp, W. van der Graaf, L. de Geus-Oei and W. Oyen. "Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [(18)F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid tumours: All that glitters is not gold.", 2016. Abstract DOI PMID

2015

Papers in international journals

G. Gebhart, L. Lamberts, Z. Wimana, C. Garcia, P. Emonts, L. Ameye, S. Stroobants, M. Huizing, P. Aftimos, J. Tol, W. Oyen, D. Vugts, O. Hoekstra, C. Schröder, C. der van Houven Menke-van Oordt, T. Guiot, A. Brouwers, A. Awada, E. de Vries and P. Flamen. "Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial.", 2015. Abstract DOI PMID
M. Boers-Sonderen, I. Desar, J. Fütterer, S. Mulder, L. De Geus-Oei, P. Mulders, W. VanDer Graaf, W. Oyen and C. Van Herpen. "Biological Effects After Discontinuation of VEGFR Inhibitors in Metastatic Renal Cell Cancer.", 2015. Abstract PMID
S. Terry, M. Koenders, G. Franssen, T. Nayak, A. Freimoser-Grundschober, C. Klein, W. Oyen, O. Boerman and P. Laverman. "Monitoring therapy response of experimental arthritis with radiolabeled tracers targeting fibroblasts, macrophages or integrin $alpha$v$beta$3.", 2015. Abstract DOI PMID
B. Bulten, H. Verberne, L. Bellersen, W. Oyen, A. Sabaté-Llobera, A. Mavinkurve-Groothuis, L. Kapusta, H. van Laarhoven and L. de Geus-Oei. "Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients.", 2015. Abstract DOI PMID
S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, C. Wauters, L. Strobbe, C. Mandigers, P. Bult, W. Oyen, W. van der Graaf and H. van Laarhoven. "Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.", 2015. Abstract DOI PMID
C. Muselaers, M. Rijpkema, D. Bos, J. Langenhuijsen, W. Oyen, P. Mulders, E. Oosterwijk and O. Boerman. "Radionuclide and Fluorescence Imaging of Clear Cell Renal Cell Carcinoma Using Dual Labeled Anti-Carbonic Anhydrase IX Antibody G250.", 2015. Abstract DOI PMID
E. Quak, I. Kovacs, W. Oyen and W. van der Graaf. "FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment.", 2015. Abstract DOI PMID
E. Troost, D. Thorwarth and W. Oyen. "Imaging-Based Treatment Adaptation in Radiation Oncology.", 2015. Abstract DOI PMID
M. Rijpkema, D. Bos, A. Cornelissen, G. Franssen, D. Goldenberg, W. Oyen and O. Boerman. "Optimization of Dual-Labeled Antibodies for Targeted Intraoperative Imaging of Tumors.", 2015.
W. der Woliner-van Weg, R. Schoffelen, R. Hobbs, M. Gotthardt, D. Goldenberg, R. Sharkey, C. Slump, W. van der Graaf, W. Oyen, O. Boerman and others. "Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy", 2015.
S. Heskamp, W. Hobo, J. Molkenboer-Kuenen, D. Olive, W. Oyen, H. Dolstra and O. Boerman. "Non-invasive imaging of tumor PD-L1 expression using radiolabeled anti-PD-L1 antibodies", 2015. Abstract/PDF DOI PMID
S. Terry, O. Boerman, D. Gerrits, G. Franssen, J. Metselaar, S. Lehmann, W. Oyen, C. Gerdes and K. Abiraj. "(111)In-anti-F4/80-A3-1 antibody: a novel tracer to image macrophages", 2015. Abstract/PDF DOI PMID
L. Heijmen, E. Ter Voert, W. Oyen, C. Punt, D. van Spronsen, A. Heerschap, L. de Geus-Oei and H. van Laarhoven. "Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer", 2015. Abstract/PDF DOI PMID
P. Laverman, T. van der Geest, S. Terry, D. Gerrits, B. Walgreen, M. Helsen, T. Nayak, A. Freimoser-Grundschober, I. Waldhauer, R. Hosse, E. Moessner, P. Umana, C. Klein, W. Oyen, M. Koenders and O. Boerman. "ImmunoPET and immunoSPECT of rheumatoid arthritis with radiolabeled anti-fibroblast activation protein (FAP) antibody correlates with severity of arthritis", 2015. Abstract/PDF DOI PMID
M. Rijpkema, O. Boerman and W. Oyen. "Tumor Targeting using Radiolabeled Antibodies for Image-Guided Drug Delivery", 2015. Abstract PMID
C. van Rij, C. Frielink, D. Goldenberg, R. Sharkey, G. Franssen, S. Lütje, W. McBride, W. Oyen and O. Boerman. "Pretargeted ImmunoPET of Prostate Cancer with an Anti-TROP-2 x Anti-HSG Bispecific Antibody in Mice with PC3 Xenografts", 2015. Abstract/PDF DOI PMID
S. Lütje, C. van Rij, G. Franssen, G. Fracasso, W. Helfrich, A. Eek, W. Oyen, M. Colombatti and O. Boerman. "Targeting human prostate cancer with (111) In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts", 2015. Abstract/PDF DOI PMID

2014

Papers in international journals

F. van de Watering, M. Rijpkema, M. Robillard, W. Oyen and O. Boerman. "Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry", 2014.
C. van Rij, C. Frielink, D. Goldenberg, R. Sharkey, S. Lütje, W. McBride, W. Oyen and O. Boerman. "Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2$times$Anti-HSG Bispecific Antibody and a (177)Lu-Labeled Peptide", 2014. Abstract/PDF DOI PMID
S. Terry, M. Rijpkema, K. Abiraj, W. van der Graaf, W. Oyen and O. Boerman. "Radiolabeled imaging probes targeting angiogenesis for personalized medicine", 2014. Abstract PMID
S. Terry, K. Abiraj, J. Lok, D. Gerrits, G. Franssen, W. Oyen and O. Boerman. "Can 111In-RGD2 Monitor Response to Therapy in Head and Neck Tumor Xenografts?", 2014. Abstract/PDF DOI PMID
C. van der Vos, W. Grootjans, A. Meeuwis, C. Slump, W. Oyen, L. de Geus-Oei and E. Visser. "Comparison of a Free-Breathing CT and an Expiratory Breath-Hold CT with Regard to Spatial Alignment of Amplitude-Based Respiratory-Gated PET and CT Images", 2014. Abstract DOI PMID
S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, F. Sweep, A. Geurts-Moespot, M. Engelhardt, W. van der Graaf, W. Oyen and H. van Laarhoven. "Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without altering VEGF expression", 2014. Abstract/PDF DOI PMID
S. Lütje, M. Rijpkema, D. Goldenberg, C. van Rij, R. Sharkey, W. McBride, G. Franssen, C. Frielink, W. Helfrich, W. Oyen and O. Boerman. "Pretargeted Dual-Modality Immuno-SPECT and Near-Infrared Fluorescence Imaging for Image-Guided Surgery of Prostate Cancer", 2014. Abstract/PDF DOI PMID
O. Schuurbiers, T. Meijer, J. Kaanders, M. Looijen-Salamon, L. de Geus-Oei, M. van der Drift, E. van der Heijden, W. Oyen, E. Visser, P. Span and J. Bussink. "Glucose Metabolism in NSCLC Is Histology-Specific and Diverges the Prognostic Potential of 18FDG-PET for Adenocarcinoma and Squamous Cell Carcinoma", 2014. Abstract DOI PMID
W. Grootjans, L. de Geus-Oei, A. Meeuwis, C. van der Vos, M. Gotthardt, W. Oyen and E. Visser. "Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer", 2014. Abstract/PDF DOI PMID
E. Fleuren, Y. Versleijen-Jonkers, S. Heskamp, C. van Herpen, W. Oyen, W. van der Graaf and O. Boerman. "Theranostic applications of antibodies in oncology", 2014. Abstract/PDF DOI PMID
E. Fleuren, Y. Versleijen-Jonkers, M. Roeffen, G. Franssen, U. Flucke, P. Houghton, W. Oyen, O. Boerman and W. van der Graaf. "Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models", 2014. Abstract/PDF DOI PMID
F. Giammarile, N. Alazraki, J. Aarsvold, R. Audisio, E. Glass, S. Grant, J. Kunikowska, M. Leidenius, V. Moncayo, R. Uren, W. Oyen, R. Olmos and S. Sicart. "Response to comment by Aprile et al.: the EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer", 2014. PDF DOI PMID
L. Heijmen, E. Ter Voert, C. Punt, A. Heerschap, W. Oyen, J. Bussink, C. Sweep, P. Laverman, P. Span, L. de Geus-Oei, O. Boerman and H. van Laarhoven. "Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model", 2014. Abstract DOI PMID
I. Kouijzer, C. Bleeker-Rovers and W. Oyen. "18F-FDG PET/CT for the Detection of Septic Embolisms in Patients with Infectious Endocarditis", 2014. PDF DOI PMID
S. Lütje, M. Rijpkema, G. Franssen, G. Fracasso, W. Helfrich, A. Eek, W. Oyen, M. Colombatti and O. Boerman. "Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody", 2014. Abstract/PDF DOI PMID
S. Lütje, M. Rijpkema, W. Helfrich, W. Oyen and O. Boerman. "Targeted Radionuclide and Fluorescence Dual-modality Imaging of Cancer: Preclinical Advances and Clinical Translation", 2014. Abstract/PDF DOI PMID
A. Maurer, P. Elsinga, S. Fanti, B. Nguyen, W. Oyen and W. Weber. "Imaging the folate receptor on cancer cells with 99mTc-etarfolatide: properties, clinical use, and future potential of folate receptor imaging", 2014. Abstract/PDF DOI PMID
C. Muselaers, E. Oosterwijk, D. Bos, W. Oyen, P. Mulders and O. Boerman. "Optimizing lutetium 177-anti-carbonic anhydrase IX radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model", 2014. Abstract PMID
C. Muselaers, A. Stillebroer, M. Rijpkema, G. Franssen, E. Oosterwijk, P. Mulders, W. Oyen and O. Boerman. "Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab", 2014. Abstract/PDF DOI PMID
T. Plantinga, B. Heinhuis, D. Gerrits, M. Netea, L. Joosten, A. Hermus, W. Oyen, R. Schweppe, B. Haugen, O. Boerman, J. Smit and R. Netea-Maier. "mTOR Inhibition Promotes TTF1-Dependent Redifferentiation and Restores Iodine Uptake in Thyroid Carcinoma Cell Lines", 2014. Abstract/PDF DOI PMID
G. Blokhuis, C. Bleeker-Rovers, M. Diender, W. Oyen, J. Draaisma and L. de Geus-Oei. "Diagnostic value of FDG-PET/(CT) in children with fever of unknown origin and unexplained fever during immune suppression", 2014. Abstract/PDF DOI PMID
M. Rijpkema, W. Oyen, D. Bos, G. Franssen, D. Goldenberg and O. Boerman. "SPECT- and Fluorescence Image-Guided Surgery Using a Dual-Labeled Carcinoembryonic Antigen-Targeting Antibody", 2014. Abstract/PDF DOI PMID
D. Vriens, E. Adang, R. Netea-Maier, J. Smit, J. de Wilt, W. Oyen and L. de Geus-Oei. "Cost-Effectiveness of FDG-PET/CT for Cytologically Indeterminate Thyroid Nodules: a Decision Analytic Approach", 2014. Abstract/PDF DOI PMID
M. Brom, O. Boerman, M. Gotthardt and W. Oyen. "Preclinical Studies of SPECT and PET Tracers for NET", 2014. Abstract DOI PMID
S. Roosenburg, P. Laverman, L. Joosten, M. Cooper, P. Kolenc-Peitl, J. Foster, C. Hudson, J. Leyton, J. Burnet, W. Oyen, P. Blower, S. Mather, O. Boerman and J. Sosabowski. "PET and SPECT Imaging of a Radiolabeled Minigastrin Analogue Conjugated with DOTA, NOTA, and NODAGA and Labeled with (64)Cu, (68)Ga, and (111)In", 2014. Abstract/PDF DOI PMID
F. van de Watering, M. Rijpkema, L. Perk, U. Brinkmann, W. Oyen and O. Boerman. "Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients", 2014. Abstract/PDF DOI PMID
R. Schoffelen, W. der Woliner-van Weg, E. Visser, D. Goldenberg, R. Sharkey, W. McBride, C. Chang, E. Rossi, W. van der Graaf, W. Oyen and O. Boerman. "Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer", 2014. Abstract/PDF DOI PMID
C. Doll, V. Duncker-Rohr, G. Rücker, M. Mix, M. Macmanus, D. Ruysscher, W. Vogel, J. Eriksen, W. Oyen, A. Grosu, W. Weber and U. Nestle. "Influence of experience and qualification on PET-based target volume delineation : When there is no expert-ask your colleague", 2014. Abstract/PDF DOI PMID
F. Giammarile, M. Bozkurt, D. Cibula, J. Pahisa, W. Oyen, P. Paredes, R. Olmos and S. Sicart. "The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers", 2014. Abstract/PDF DOI PMID
A. Arens, E. Troost, B. Hoeben, W. Grootjans, J. Lee, V. Grégoire, M. Hatt, D. Visvikis, J. Bussink, W. Oyen, J. Kaanders and E. Visser. "Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome", 2014. Abstract/PDF DOI PMID
A. Bex, L. Fournier, N. Lassau, P. Mulders, P. Nathan, W. Oyen and T. Powles. "Assessing the Response to Targeted Therapies in Renal Cell Carcinoma: Technical Insights and Practical Considerations", 2014. Abstract/PDF DOI PMID
M. Boers-Sonderen, L. de Geus-Oei, I. Desar, W. van der Graaf, W. Oyen, P. Ottevanger and C. van Herpen. "Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT", 2014. Abstract/PDF DOI PMID
M. Brom, W. der Woliner-van Weg, L. Joosten, C. Frielink, T. Bouckenooghe, P. Rijken, K. Andralojc, B. Göke, M. de Jong, D. Eizirik, M. Béhé, T. Lahoutte, W. Oyen, C. Tack, M. Janssen, O. Boerman and M. Gotthardt. "Non-invasive quantification of the beta cell mass by SPECT with (111)In-labelled exendin", 2014. Abstract/PDF DOI PMID
S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, R. Koornstra, S. Linn, W. Oyen, W. van der Graaf and H. van Laarhoven. "Dynamics of IGF-1R Expression During Endocrine Breast Cancer Treatment", 2014. Abstract/PDF DOI PMID
S. Heskamp, H. van Laarhoven, W. van der Graaf, W. Oyen and O. Boerman. "Radionuclide imaging of drug delivery for patient selection in targeted therapy", 2014. Abstract/PDF DOI PMID
B. Hoeben, E. Troost, J. Bussink, C. van Herpen, W. Oyen and J. Kaanders. "18F-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients", 2014. Abstract DOI PMID
R. van Hoorn, D. Vriens, J. Postema, A. Arens, A. Pfestroff, W. Oyen and M. Gotthardt. "The influence of SPECT reconstruction algorithms on image quality and diagnostic accuracy in phantom measurements and 99mTc-sestamibi parathyroid scintigraphy", 2014. Abstract DOI PMID
S. Lütje, G. Franssen, R. Sharkey, P. Laverman, E. Rossi, D. Goldenberg, W. Oyen, O. Boerman and W. McBride. "Anti-CEA Antibody Fragments Labeled with [(18)F]AlF for PET Imaging of CEA-Expressing Tumors", 2014. Abstract/PDF DOI PMID
C. Muselaers, A. Stillebroer, I. Desar, M. Boers-Sonderen, C. van Herpen, M. de Weijert, J. Langenhuijsen, E. Oosterwijk, W. Leenders, O. Boerman, P. Mulders and W. Oyen. "Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma", 2014. Abstract/PDF DOI PMID
D. Stevens, S. Al-Nasiry, M. Fajta, J. Bulten, A. van Dijk, M. van der Vlugt, W. Oyen, J. van Vugt and M. Spaanderman. "Cardiovascular and thrombogenic risk of decidual vasculopathy in preeclampsia", 2014. Abstract/PDF DOI PMID
E. Ter Voert, H. van Laarhoven, P. Kok, W. Oyen, E. Visser and L. de Geus-Oei. "Comparison of liver SUV using unenhanced CT versus contrast-enhanced CT for attenuation correction in 18F-FDG PET/CT", 2014. Abstract DOI PMID
S. Terry, K. Abiraj, C. Frielink, L. van Dijk, J. Bussink, W. Oyen and O. Boerman. "Imaging Integrin ÃŽÂ±vÃŽÂ²3 on Blood Vessels with 111In-RGD2 in Head and Neck Tumor Xenografts", 2014. Abstract/PDF DOI PMID

2013

Papers in international journals

E. Aarntzen, M. Srinivas, C. Radu, C. Punt, O. Boerman, C. Figdor, W. Oyen and I. de Vries. "In vivo imaging of therapy-induced anti-cancer immune responses in humans", 2013. Abstract/PDF DOI PMID
D. Barten, C. Delsing, S. Keijmel, T. Sprong, J. Timmermans, W. Oyen, M. Nabuurs-Franssen and C. Bleeker-Rovers. "Localizing chronic Q fever: a challenging query", 2013. Abstract/PDF DOI PMID
W. van der Bruggen, A. Arens, M. van der Drift, L. de Geus-Oei, M. Gotthardt and W. Oyen. "Referred shoulder pain in a patient with small cell lung cancer. Adrenal gland metastases", 2013. PMID
I. Dijkgraaf, S. Terry, W. McBride, D. Goldenberg, P. Laverman, G. Franssen, W. Oyen and O. Boerman. "Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide", 2013. Abstract DOI PMID
E. Fleuren, Y. Versleijen-Jonkers, S. Heskamp, M. Roeffen, W. Bouwman, J. Molkenboer-Kuenen, H. van Laarhoven, W. Oyen, O. Boerman and W. van der Graaf. "The strength of small: improved targeting of insulin-like growth factor-1 receptor (IGF-1R) with F(ab')Ã¢â€šâ€š-R1507 fragments in Ewing sarcomas", 2013. Abstract/PDF DOI PMID
L. de Geus-Oei, A. Mavinkurve-Groothuis, L. Bellersen, M. Gotthardt, W. Oyen, L. Kapusta and H. van Laarhoven. "Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity", 2013. Abstract/PDF DOI PMID
M. Gotthardt, C. Bleeker-Rovers, O. Boerman and W. Oyen. "Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques", 2013. Abstract DOI PMID
S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, W. Oyen, W. van der Graaf and H. van Laarhoven. "Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies", 2013. Abstract DOI PMID
B. Hoeben, E. Troost, P. Span, C. van Herpen, J. Bussink, W. Oyen and J. Kaanders. "18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome", 2013. Abstract DOI PMID
I. Kouijzer, F. Vos, M. Janssen, A. van Dijk, C. Bleeker-Rovers and W. Oyen. "Reply to comment by Treglia and Bertagna: FDG PET/CT for detection of infectious endocarditis", 2013. PDF DOI PMID
I. Kouijzer, F. Vos, M. Janssen, A. van Dijk, W. Oyen and C. Bleeker-Rovers. "The value of 18F-FDG PET/CT in diagnosing infectious endocarditis", 2013. Abstract/PDF DOI PMID
D. Mönnich, E. Troost, J. Kaanders, W. Oyen, M. Alber, D. Zips and D. Thorwarth. "Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images", 2013. Abstract/PDF DOI PMID
C. Muselaers, O. Boerman, E. Oosterwijk, J. Langenhuijsen, W. Oyen and P. Mulders. "Reply to John Samuel Banerji's letter to the editor re: Constantijn H.J. Muselaers, Otto C. Boerman, Egbert Oosterwijk, Johannes F. Langenhuijsen, Wim J.G. Oyen, Peter F.A. Mulders. Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma. Eur Urol 2013;63:1101-6", 2013. PDF DOI PMID
C. Muselaers, O. Boerman, E. Oosterwijk, J. Langenhuijsen, W. Oyen and P. Mulders. "Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma", 2013. Abstract/PDF DOI PMID
S. Muselaers, P. Mulders, E. Oosterwijk, W. Oyen and O. Boerman. "Molecular imaging and carbonic anhydrase IX-targeted radioimmunotherapy in clear cell renal cell carcinoma", 2013. Abstract DOI PMID
C. van Rij, S. Lütje, C. Frielink, R. Sharkey, D. Goldenberg, G. Franssen, W. McBride, E. Rossi, W. Oyen and O. Boerman. "Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody", 2013. Abstract/PDF DOI PMID
D. Schinagl, P. Span, F. van den Hoogen, M. Merkx, P. Slootweg, W. Oyen and J. Kaanders. "Pathology-based validation of FDG PET segmentation tools for volume assessment of lymph node metastases from head and neck cancer", 2013. Abstract/PDF DOI PMID
R. Schoffelen, O. Boerman, D. Goldenberg, R. Sharkey, C. van Herpen, G. Franssen, W. McBride, C. Chang, E. Rossi, W. van der Graaf and W. Oyen. "Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results", 2013. Abstract/PDF DOI PMID
R. Scholten, M. Hopman, F. Sweep, M. de Van Vlugt, A. Van Dijk, W. Oyen, F. Lotgering and M. Spaanderman. "Co-occurrence of cardiovascular and prothrombotic risk factors in women with a history of preeclampsia", 2013. Abstract DOI PMID
A. Stillebroer, O. Boerman, I. Desar, M. Boers-Sonderen, C. van Herpen, J. Langenhuijsen, P. Smith-Jones, E. Oosterwijk, W. Oyen and P. Mulders. "Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma", 2013. Abstract/PDF DOI PMID
A. Stillebroer, G. Franssen, P. Mulders, W. Oyen, G. van Dongen, P. Laverman, E. Oosterwijk and O. Boerman. "ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice", 2013. Abstract DOI PMID
J. Tel, E. Aarntzen, T. Baba, G. Schreibelt, B. Schulte, D. Benitez-Ribas, O. Boerman, S. Croockewit, W. Oyen, M. van Rossum, G. Winkels, P. Coulie, C. Punt, C. Figdor and I. de Vries. "Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients", 2013. Abstract DOI PMID
F. Vos, C. Bleeker-Rovers and W. Oyen. "The use of FDG-PET/CT in patients with febrile neutropenia", 2013. Abstract/PDF DOI PMID
S. Heskamp, H. van Laarhoven, W. Oyen, W. van der Graaf and O. Boerman. "Tumor-receptor imaging in breast cancer: a tool for patient selection and response monitoring", 2013. Abstract PMID
W. Oyen, J. Kaanders and J. Bussink. "Molecular imaging of hypoxia", 2013. PMID
R. Wijsman, J. Kaanders, W. Oyen and J. Bussink. "Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography", 2013. Abstract PMID
N. Ayez, J. de Ridder, B. Wiering, W. Oyen, J. de Wilt and C. Verhoef. "Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score", 2013. Abstract DOI PMID
F. Giammarile, N. Alazraki, J. Aarsvold, R. Audisio, E. Glass, S. Grant, J. Kunikowska, M. Leidenius, V. Moncayo, R. Uren, W. Oyen, R. Valdés Olmos and S. Vidal Sicart. "The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer", 2013. Abstract/PDF DOI PMID
E. Aarntzen, M. Srinivas, G. Schreibelt, A. Heerschap, C. Punt, C. Figdor, W. Oyen and I. de Vries. "Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination", 2013. Abstract/PDF DOI PMID
L. Heijmen, C. Punt, E. Ter Voert, L. de Geus-Oei, A. Heerschap, J. Bussink, C. Sweep, V. Zerbi, W. Oyen, P. Span, O. Boerman and H. van Laarhoven. "Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach", 2013. Abstract/PDF DOI PMID
H. Meijer, O. Debats, E. van Th Lin, M. van Vulpen, J. Witjes, W. Oyen, J. Barentsz and J. Kaanders. "Individualized image-based lymph node irradiation for prostate cancer", 2013. Abstract DOI PMID
E. Aarntzen, M. Srinivas, F. Bonetto, L. Cruz, P. Verdijk, G. Schreibelt, M. van de Rakt, W. Lesterhuis, M. Van Riel, C. Punt, G. Adema, A. Heerschap, C. Figdor, W. Oyen and I. de Vries. "Targeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells", 2013. Abstract/PDF DOI PMID

2012

Papers in international journals

R. Schoffelen, W. van der Graaf, R. Sharkey, G. Franssen, W. McBride, C. Chang, D. Bos, D. Goldenberg, W. Oyen and O. Boerman. "Quantitative immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in an intraperitoneal nude mouse model of human colon cancer", 2012. Abstract DOI PMID
E. Aarntzen, M. Srinivas, C. Punt, C. Figdor, W. Oyen and I. de Vries. "Insight into the dynamics, localization and magnitude of antigen-specific immune responses by [(18)F]FLT PET imaging", 2012. Abstract/PDF DOI PMID
E. Aarts, R. Helmich, M. Janssen, W. Oyen, B. Bloem and R. Cools. "Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss", 2012. Abstract/PDF DOI PMID
H. Aerts, J. Bussink, W. Oyen, W. van Elmpt, A. Folgering, D. Emans, M. Velders, P. Lambin and D. De Ruysscher. "Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation", 2012. Abstract/PDF DOI PMID
M. Brom, L. Joosten, W. Oyen, M. Gotthardt and O. Boerman. "Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with 111In in HEPES and MES buffer", 2012. Abstract/PDF DOI PMID
M. Brom, L. Joosten, W. Oyen, M. Gotthardt and O. Boerman. "Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas", 2012. Abstract DOI PMID
I. Dijkgraaf, G. Franssen, W. McBride, C. D'Souza, P. Laverman, C. Smith, D. Goldenberg, W. Oyen and O. Boerman. "PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog", 2012. Abstract/PDF DOI PMID
J. Donckers, R. Scholten, W. Oyen, M. Hopman, F. Lotgering and M. Spaanderman. "Unexplained first trimester recurrent pregnancy loss and low venous reserves", 2012. Abstract/PDF DOI PMID
L. Heijmen, L. de Geus-Oei, J. de Wilt, D. Visvikis, M. Hatt, E. Visser, J. Bussink, C. Punt, W. Oyen and H. van Laarhoven. "Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer", 2012. Abstract/PDF DOI PMID
S. Heskamp, H. van Laarhoven, J. Molkenboer-Kuenen, W. Bouwman, W. van der Graaf, W. Oyen and O. Boerman. "Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507", 2012. Abstract/PDF DOI PMID
S. Heskamp, P. Laverman, D. Rosik, F. Boschetti, W. van der Graaf, W. Oyen, H. van Laarhoven, V. Tolmachev and O. Boerman. "Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer", 2012. Abstract/PDF DOI PMID
S. Lütje, O. Boerman, C. van Rij, M. Sedelaar, W. Helfrich, W. Oyen and P. Mulders. "Prospects in radionuclide imaging of prostate cancer", 2012. Abstract/PDF DOI PMID
P. Laverman, C. D'Souza, A. Eek, W. McBride, R. Sharkey, W. Oyen, D. Goldenberg and O. Boerman. "Optimized labeling of NOTA-conjugated octreotide with F-18", 2012. Abstract/PDF DOI PMID
P. Laverman, J. Sosabowski, O. Boerman and W. Oyen. "Radiolabelled peptides for oncological diagnosis", 2012. Abstract/PDF DOI PMID
D. Mönnich, E. Troost, J. Kaanders, W. Oyen, M. Alber and D. Thorwarth. "Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging", 2012. Abstract/PDF DOI PMID
A. Stillebroer, C. Zegers, O. Boerman, E. Oosterwijk, P. Mulders, J. O'Donoghue, E. Visser and W. Oyen. "Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging", 2012. Abstract/PDF DOI PMID
D. Thorwarth, T. Beyer, R. Boellaard, D. de Ruysscher, A. Grgic, J. Lee, U. Pietrzyk, B. Sattler, A. Schaefer, W. van Elmpt, W. Vogel, W. Oyen and U. Nestle. "Integration of FDG-PET/CT into external beam radiation therapy planning: technical aspects and recommendations on methodological approaches", 2012. Abstract/PDF DOI PMID
F. Vos, J. Donnelly, W. Oyen, B. Kullberg, C. Bleeker-Rovers and N. Blijlevens. "18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation", 2012. Abstract/PDF DOI PMID
F. Vos, B. Kullberg, P. Sturm, P. Krabbe, A. van Dijk, G. Wanten, W. Oyen and C. Bleeker-Rovers. "Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia", 2012. Abstract DOI PMID
D. Vriens, J. Disselhorst, W. Oyen, L. de Geus-Oei and E. Visser. "Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET", 2012. Abstract/PDF DOI PMID
C. Wouters, P. Meijer, C. Janssen, G. Frederix, W. Oyen, O. Boerman, P. Smits and G. Rongen. "Atorvastatin does not affect ischaemia-induced phosphatidylserine exposition in humans in-vivo", 2012. Abstract PMID
O. Boerman, P. Laverman and W. Oyen. "FIAU: From reporter gene imaging to imaging of bacterial proliferation", 2012. Abstract PMID
I. Desar, R. Gilles, C. van Herpen, A. Timmer-Bonte, M. Cantarini, W. van der Graaf and W. Oyen. "(18)F-FLT-PET for Response Evaluation of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with Solid Tumors", 2012. Abstract/PDF DOI PMID
R. Engbersen, N. Riksen, M. Mol, B. Bravenboer, O. Boerman, P. Meijer, W. Oyen, C. Tack, G. Rongen and P. Smits. "Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study", 2012. Abstract/PDF DOI PMID
L. de Geus-Oei, D. Vriens, A. Arens, M. Hutchings and W. Oyen. "FDG-PET/CT based response-adapted treatment", 2012. Abstract DOI PMID
R. Schoffelen, W. van der Graaf, R. Sharkey, G. Franssen, W. McBride, C. Chang, P. Laverman, D. Goldenberg, W. Oyen, O. Boerman, R. Schoffelen, W. van der Graaf, R. Sharkey, G. Franssen, W. McBride, C. Chang, D. Bos, D. Goldenberg, W. Oyen and O. Boerman. "Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method", 2012. Abstract DOI PMID
P. Teeuwen, L. de Geus-Oei, T. Hendriks, H. van Goor, A. Bremers, W. Oyen and R. Bleichrodt. "Hybrid 18F-FDG PET/CT of colonic anastomosis. A possibility to detect anastomotic leakage?", 2012. Abstract DOI PMID
A. Arens, B. Verbist, B. Hendrickx, L. de Geus-Oei and W. Oyen. "False positive 18F-FDG PET/CT due to inflamed concha bullosa", 2012. Abstract DOI PMID
E. Aarntzen, M. Srinivas, P. Walczak, M. Janowski, A. Heerschap, I. de Vries, C. Figdor, J. Bulte and W. Oyen. "In Vivo Tracking Techniques for Cellular Regeneration, Replacement, and Redirection", 2012. Abstract/PDF DOI PMID
L. Heijmen, M. Verstappen, E. Ter Voert, C. Punt, W. Oyen, L. de Geus-Oei, J. Hermans, A. Heerschap and H. van Laarhoven. "Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use?", 2012. Abstract/PDF DOI PMID
A. Idema, A. Hoffmann, H. Boogaarts, E. Troost, P. Wesseling, A. Heerschap, W. van der Graaf, J. Grotenhuis and W. Oyen. "3'-Deoxy-3'-18F-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients", 2012. Abstract/PDF DOI PMID
G. de Jong, T. Hendriks, R. Bleichrodt, H. Dekker, R. Mus, M. Gotthardt, E. Visser, W. Oyen and O. Boerman. "(18)F-2-deoxy-2-fluoro-D-glucose positron emission tomography, computed tomography, and magnetic resonance imaging for the detection of experimental colorectal liver metastases", 2012. Abstract PMID

2011

Papers in international journals

I. Desar, J. Jacobs, C. Hulsbergen-vandeKaa, W. Oyen, P. Mulders, W. van der Graaf, G. Adema, C. van Herpen and I. de Vries. "Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients", 2011. Abstract DOI PMID
I. Dijkgraaf, C. Yim, G. Franssen, R. Schuit, G. Luurtsema, S. Liu, W. Oyen and O. Boerman. "PET imaging of $alpha$v$beta$Ã¢â€šÆ’ integrin expression in tumours with Ã¯Â¿Â½?Ã¯Â¿Â½Ã¯Â¿Â½?Ã¯Â¿Â½Ga-labelled mono-, di- and tetrameric RGD peptides", 2011. Abstract DOI PMID
B. Hoeben, J. Molkenboer-Kuenen, W. Oyen, W. Peeters, J. Kaanders, J. Bussink and O. Boerman. "Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model", 2011. Abstract DOI PMID
G. de Jong, T. Hendriks, G. Franssen, W. Oyen, O. Boerman and R. Bleichrodt. "Adjuvant radioimmunotherapy after radiofrequency ablation of colorectal liver metastases in an experimental model", 2011. Abstract/PDF DOI PMID
E. Vegt, M. Melis, A. Eek, M. de Visser, M. Brom, W. Oyen, M. Gotthardt, M. de Jong and O. Boerman. "Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice", 2011. Abstract/PDF DOI PMID
A. Arens, E. Troost, D. Schinagl, J. Kaanders and W. Oyen. "FDG-PET/CT in radiation treatment planning of head and neck squamous cell carcinoma", 2011. Abstract PMID
C. Bleeker-Rovers, F. Vos, W. van der Graaf and W. Oyen. "Nuclear medicine imaging of infection in cancer patients (with emphasis on FDG-PET)", 2011. Abstract DOI PMID
O. Boerman and W. Oyen. "Immuno-PET of cancer: a revival of antibody imaging", 2011. DOI PMID
M. Brom, L. Joosten, P. Laverman, W. Oyen, M. Béhé, M. Gotthardt and O. Boerman. "Preclinical evaluation of 68Ga-DOTA-minigastrin for the detection of cholecystokinin-2/gastrin receptor-positive tumors", 2011. Abstract PMID
J. Bussink, J. Kaanders, W. van der Graaf and W. Oyen. "PET-CT for radiotherapy treatment planning and response monitoring in solid tumors", 2011. Abstract DOI PMID
A. Chiti and W. Oyen. "Imaging of therapy response in oncology", 2011. PMID
J. Disselhorst, D. Vriens, L. de Geus-Oei, W. Oyen and E. Visser. "Shortened dynamic (18)F-FDG PET", 2011. PDF DOI PMID
E. Fleuren, Y. Versleijen-Jonkers, A. van de Luijtgaarden, J. Molkenboer-Kuenen, S. Heskamp, M. Roeffen, H. van Laarhoven, P. Houghton, W. Oyen, O. Boerman and W. van der Graaf. "Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507", 2011. Abstract DOI PMID
A. Harteveld, A. Meeuwis, J. Disselhorst, C. Slump, W. Oyen, O. Boerman and E. Visser. "Using the NEMA NU 4 PET image quality phantom in multipinhole small-animal SPECT", 2011. Abstract/PDF DOI PMID
R. Helmich, M. Janssen, W. Oyen, B. Bloem and I. Toni. "Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor", 2011. Abstract DOI PMID
G. de Jong, R. Bleichrodt, A. Eek, W. Oyen, O. Boerman and T. Hendriks. "Experimental study of radioimmunotherapy versus chemotherapy for colorectal cancer", 2011. Abstract DOI PMID
G. de Jong, T. Hendriks, A. Eek, W. Oyen, I. Nagtegaal, R. Bleichrodt and O. Boerman. "Adjuvant radioimmunotherapy improves survival of rats after resection of colorectal liver metastases", 2011. Abstract DOI PMID
R. Keijsers, E. Verzijlbergen, J. van den Bosch, P. Zanen, E. van de Garde, W. Oyen and J. Grutters. "18F-FDG PET as a predictor of pulmonary function in sarcoidosis", 2011. Abstract PMID
P. Laverman, L. Joosten, A. Eek, S. Roosenburg, P. Peitl, T. Maina, H. Mäcke, L. Aloj, E. von Guggenberg, J. Sosabowski, M. de Jong, J. Reubi, W. Oyen and O. Boerman. "Comparative biodistribution of 12 textsuperscript1textsuperscript1textsuperscript1In-labelled gastrin/CCK2 receptor-targeting peptides", 2011. Abstract/PDF DOI PMID
D. Mönnich, E. Troost, J. Kaanders, W. Oyen, M. Alber and D. Thorwarth. "Modelling and simulation of [18F]fluoromisonidazole dynamics based on histology-derived microvessel maps", 2011. Abstract/PDF DOI PMID
P. Meijer, C. Wouters, W. Oyen, O. Boerman, G. Scheffer, P. Smits and G. Rongen. "Angiotensin II type 1 receptor blockade does not enhance apoptotic cell death during ischemia and reperfusion in humans in vivo", 2011. Abstract DOI PMID
W. Oyen, H. Marres and J. Kaanders. "Progress in nuclear medicine procedures in head and neck oncology", 2011. PMID
E. Quak, A. van de Luijtgaarden, L. de Geus-Oei, W. van der Graaf and W. Oyen. "Clinical applications of positron emission tomography in sarcoma management", 2011. Abstract DOI PMID
C. van Rij, R. Sharkey, D. Goldenberg, C. Frielink, J. Molkenboer, G. Franssen, W. van Weerden, W. Oyen and O. Boerman. "Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody", 2011. Abstract/PDF DOI PMID
D. Schinagl, P. Span, W. Oyen and J. Kaanders. "Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study", 2011. Abstract/PDF DOI PMID
R. Scholten, W. Oyen, M. der Van Vlugt, A. Van Dijk, M. Hopman, F. Lotgering and M. Spaanderman. "Impaired fetal growth and low plasma volume in adult life", 2011. Abstract DOI PMID
F. Vos, C. Bleeker-Rovers, B. Kullberg, E. Adang and W. Oyen. "Cost-effectiveness of routine (18)F-FDG PET/CT in high-risk patients with gram-positive bacteremia", 2011. Abstract/PDF DOI PMID
F. Vos, C. Bleeker-Rovers, P. Sturm, P. Krabbe, A. van Dijk, W. Oyen and B. Kullberg. "Endocarditis: effects of routine echocardiography during Gram-positive bacteraemia", 2011. Abstract PMID
D. Vriens, J. de Wilt, G. van der Wilt, R. Netea-Maier, W. Oyen and L. de Geus-Oei. "The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature", 2011. Abstract DOI PMID
B. Wiering, W. Oyen, E. Adang, J. van der Sijp, R. Roumen, K. de Jong, T. Ruers and P. Krabbe. "Long-term global quality of life in patients treated for colorectal liver metastases", 2011. Abstract DOI PMID
E. Aarntzen, M. Srinivas, J. De Wilt, J. Jacobs, W. Lesterhuis, A. Windhorst, E. Troost, J. Bonenkamp, M. van Rossum, W. Blokx, R. Mus, O. Boerman, C. Punt, C. Figdor, W. Oyen and I. de Vries. "Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging", 2011. Abstract/PDF DOI PMID
W. Lesterhuis, I. de Vries, G. Schreibelt, A. Lambeck, E. Aarntzen, J. Jacobs, N. Scharenborg, M. van de Rakt, A. de Boer, S. Croockewit, M. van Rossum, R. Mus, W. Oyen, O. Boerman, S. Lucas, G. Adema, C. Punt and C. Figdor. "Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients", 2011. Abstract/PDF DOI PMID
S. Heijmink, J. Fütterer, S. Strum, W. Oyen, F. Frauscher, J. Witjes and J. Barentsz. "State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer", 2011. Abstract/PDF DOI PMID
D. Vriens, L. de Geus-Oei, A. Heerschap, H. van Laarhoven and W. Oyen. "Vascular and metabolic response to bevacizumab-containing regimens in two patients with colorectal liver metastases measured by dynamic contrast-enhanced MRI and dynamic 18F-FDG-PET", 2011. Abstract/PDF DOI PMID

2010

Papers in international journals

F. Aarts, O. Boerman, R. Sharkey, T. Hendriks, C. Chang, W. McBride, R. Bleichrodt, W. Oyen and D. Goldenberg. "Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody", 2010. Abstract DOI PMID
M. Brom, K. Andrałojć, W. Oyen, O. Boerman and M. Gotthardt. "Development of radiotracers for the determination of the beta-cell mass in vivo", 2010. Abstract PMID
M. Brom, W. Oyen, L. Joosten, M. Gotthardt and O. Boerman. "68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET", 2010. Abstract/PDF DOI PMID
W. van der Bruggen, C. Bleeker-Rovers, O. Boerman, M. Gotthardt and W. Oyen. "PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review", 2010. Abstract/PDF DOI PMID
J. Bussink, C. van Herpen, J. Kaanders and W. Oyen. "PET-CT for response assessment and treatment adaptation in head and neck cancer", 2010. Abstract/PDF DOI PMID
I. Desar, A. Stillebroer, E. Oosterwijk, W. Leenders, C. van Herpen, W. van der Graaf, O. Boerman, P. Mulders and W. Oyen. "111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib", 2010. Abstract/PDF DOI PMID
J. Disselhorst, M. Brom, P. Laverman, C. Slump, O. Boerman, W. Oyen, M. Gotthardt and E. Visser. "Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner", 2010. Abstract/PDF DOI PMID
R. Gilles, W. Vogel, C. Gidding, G. Janssens, T. van der Vliet and W. Oyen. "(18)F-fluoro-L-thymidine-PET for the evaluation of primary brain tumours in children: a report of three cases", 2010. Abstract DOI PMID
M. Gotthardt, A. Arens, E. van der Heijden, L. de Geus-Oei and W. Oyen. "Nodular fasciitis on F-18 FDG PET", 2010. Abstract DOI PMID
M. Gotthardt, C. Bleeker-Rovers, O. Boerman and W. Oyen. "Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques", 2010. Abstract/PDF DOI PMID
S. Heskamp, H. van Laarhoven, J. Molkenboer-Kuenen, G. Franssen, Y. Versleijen-Jonkers, W. Oyen, W. van der Graaf and O. Boerman. "ImmunoSPECT and immunoPET of IGF-1R expression with the radiolabeled antibody R1507 in a triple-negative breast cancer model", 2010. Abstract/PDF DOI PMID
B. Hoeben, J. Kaanders, G. Franssen, E. Troost, P. Rijken, E. Oosterwijk, G. van Dongen, W. Oyen, O. Boerman and J. Bussink. "PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors", 2010. Abstract/PDF DOI PMID
R. Keijsers, J. Grutters, H. van Velzen-Blad, J. van den Bosch, W. Oyen and F. Verzijlbergen. "(18)F-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis", 2010. Abstract/PDF DOI PMID
P. Laverman, W. McBride, R. Sharkey, A. Eek, L. Joosten, W. Oyen, D. Goldenberg and O. Boerman. "A novel facile method of labeling octreotide with (18)F-fluorine", 2010. Abstract/PDF DOI PMID
A. Rennings, P. Meijer, D. van Uden, C. Tack, P. Smits, O. Boerman, W. Oyen and G. Rongen. "Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome", 2010. PDF DOI PMID
S. Roosenburg, P. Laverman, L. Joosten, A. Eek, W. Oyen, M. de Jong, F. Rutjes, F. van Delft and O. Boerman. "Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation", 2010. Abstract/PDF DOI PMID
R. Schoffelen, W. van der Graaf, G. Franssen, R. Sharkey, D. Goldenberg, W. McBride, E. Rossi, A. Eek, W. Oyen and O. Boerman. "Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice", 2010. Abstract/PDF DOI PMID
R. Schoffelen, R. Sharkey, D. Goldenberg, G. Franssen, W. McBride, E. Rossi, C. Chang, P. Laverman, J. Disselhorst, A. Eek, W. van der Graaf, W. Oyen and O. Boerman. "Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts", 2010. Abstract DOI PMID
A. Stillebroer, P. Mulders, O. Boerman, W. Oyen and E. Oosterwijk. "Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy", 2010. Abstract/PDF DOI PMID
E. Troost, J. Bussink, A. Hoffmann, O. Boerman, W. Oyen and J. Kaanders. "18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors", 2010. Abstract/PDF DOI PMID
E. Troost, J. Bussink, P. Slootweg, W. Peeters, M. Merkx, A. van der Kogel, W. Oyen and J. Kaanders. "Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity", 2010. Abstract/PDF DOI PMID
E. Troost, D. Schinagl, J. Bussink, O. Boerman, A. van der Kogel, W. Oyen and J. Kaanders. "Innovations in radiotherapy planning of head and neck cancers: role of PET", 2010. Abstract/PDF DOI PMID
E. Troost, D. Schinagl, J. Bussink, J. Kaanders, W. Oyen and O. Boerman. "Correlation of segmented metabolic tumor volume with outcome--letter", 2010. DOI PMID
E. Troost, D. Schinagl, J. Bussink, W. Oyen and J. Kaanders. "Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours", 2010. Abstract/PDF DOI PMID
E. Vegt, A. Eek, W. Oyen, M. de Jong, M. Gotthardt and O. Boerman. "Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides", 2010. Abstract/PDF DOI PMID
E. Vegt, M. de Jong, J. Wetzels, R. Masereeuw, M. Melis, W. Oyen, M. Gotthardt and O. Boerman. "Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention", 2010. Abstract/PDF DOI PMID
E. Visser, O. Boerman and W. Oyen. "SUV: from silly useless value to smart uptake value", 2010. PDF DOI PMID
F. Vos, C. Bleeker-Rovers, C. Delsing, B. Kullberg and W. Oyen. "Bone-marrow uptake of (18)F-FDG during fever", 2010. PDF DOI PMID
F. Vos, C. Bleeker-Rovers, P. Sturm, P. Krabbe, A. van Dijk, M. Cuijpers, E. Adang, G. Wanten, B. Kullberg and W. Oyen. "18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia", 2010. Abstract/PDF DOI PMID
D. Vriens, L. de Geus-Oei, U. Flucke, A. van der Kogel, W. Oyen, M. Vierhout and J. van der Meer. "Benign uterine uptake of FDG: a case report and review of literature", 2010. PMID
D. Vriens, E. Visser, L. de Geus-Oei and W. Oyen. "Methodological considerations in quantification of oncological FDG PET studies", 2010. Abstract/PDF DOI PMID
N. Kock, E. van Tankeren, W. Oyen, A. Wymenga and J. van Susante. "Bone scintigraphy after osteochondral autograft transplantation in the knee: 13 patients followed for 4 years", 2010. Abstract/PDF DOI PMID
D. Vriens, L. De Geus-Oei, H. Van Laarhoven, H. Der Van Heijden, P. Krabbe, E. Visser and W. Oyen. "Comparison of two region of interest definition methods for metabolic response evaluation with [textsuperscript1Ã¯Â¿Â½?Ã¯Â¿Â½F]FDG-PET", 2010. Abstract PMID
R. Boellaard, M. O'Doherty, W. Weber, F. Mottaghy, M. Lonsdale, S. Stroobants, W. Oyen, J. Kotzerke, O. Hoekstra, J. Pruim, P. Marsden, K. Tatsch, C. Hoekstra, E. Visser, B. Arends, F. Verzijlbergen, J. Zijlstra, E. Comans, A. Lammertsma, A. Paans, A. Willemsen, T. Beyer, A. Bockisch, C. Schaefer-Prokop, D. Delbeke, R. Baum, A. Chiti and B. Krause. "FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0", 2010. Abstract/PDF DOI PMID
B. Dijkman, O. Schuurbiers, D. Vriens, M. Looijen-Salamon, J. Bussink, J. Timmer-Bonte, M. Snoeren, W. Oyen, H. van der Heijden and L. de Geus-Oei. "The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours", 2010. Abstract/PDF DOI PMID
M. Srinivas, E. Aarntzen, J. Bulte, W. Oyen, A. Heerschap, I. de Vries and C. Figdor. "Imaging of cellular therapies", 2010. Abstract/PDF DOI PMID
B. Wiering, E. Adang, J. van der Sijp, R. Roumen, K. de Jong, E. Comans, J. Pruim, H. Dekker, T. Ruers, P. Krabbe and W. Oyen. "Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases", 2010. Abstract DOI PMID

2009

Papers in international journals

F. Aarts, T. Hendriks, A. Eek, W. Oyen, R. Bleichrodt and O. Boerman. "Can antibody galactosylation be used to improve radioimmunotherapy of induced peritoneal carcinomatosis of colonic origin in the rat?", 2009. Abstract/PDF DOI PMID
E. Bastiaannet, T. Wobbes, O. Hoekstra, E. van der Jagt, A. Brouwers, R. Koelemij, J. de Klerk, W. Oyen, S. Meijer and H. Hoekstra. "Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment", 2009. Abstract DOI PMID
C. Bleeker-Rovers, J. van der Meer and W. Oyen. "Fever of unknown origin", 2009. Abstract/PDF DOI PMID
J. De Klerk and W. Oyen. "The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastases", 2009. Abstract PMID
I. Desar, C. van Herpen, H. van Laarhoven, J. Barentsz, W. Oyen and W. van der Graaf. "Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy", 2009. Abstract/PDF DOI PMID
A. Di Fonzo, M. Dekker, P. Montagna, A. Baruzzi, E. Yonova, L. Correia Guedes, A. Szczerbinska, T. Zhao, L. Dubbel-Hulsman, C. Wouters, E. de Graaff, W. Oyen, E. Simons, G. Breedveld, B. Oostra, M. Horstink and V. Bonifati. "FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome", 2009. Abstract/PDF DOI PMID
A. Draisma, M. de Goeij, C. Wouters, N. Riksen, W. Oyen, G. Rongen, O. Boerman, M. van Deuren, J. van der Hoeven and P. Pickkers. "Endotoxin tolerance does not limit mild ischemia-reperfusion injury in humans in vivo", 2009. Abstract/PDF DOI PMID
L. de Geus-Oei, D. Vriens, H. van Laarhoven, W. van der Graaf and W. Oyen. "Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review", 2009. Abstract/PDF DOI PMID
C. van Herpen, W. van der Graaf and W. Oyen. "Time to target evaluation criteria of targeted therapies", 2009. DOI PMID
G. de Jong, T. Hendriks, A. Eek, W. Oyen, S. Heskamp, R. Bleichrodt and O. Boerman. "Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin", 2009. Abstract/PDF DOI PMID
R. Keijsers, F. Verzijlbergen, W. Oyen, J. van den Bosch, H. Ruven, H. van Velzen-Blad and J. Grutters. "18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis", 2009. Abstract/PDF DOI PMID
I. Krabbendam, M. Maas, D. Thijssen, W. Oyen, F. Lotgering, M. Hopman and M. Spaanderman. "Exercise-induced changes in venous vascular function in nonpregnant formerly preeclamptic women", 2009. Abstract/PDF DOI PMID
H. Kyrieleis, M. Löwik, I. Pronk, H. Cruysberg, J. Kremer, W. Oyen, B. van den Heuvel, J. Wetzels and E. Levtchenko. "Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children", 2009. Abstract DOI PMID
H. van Laarhoven, M. Vinken, R. Mus, U. Flucke, W. Oyen and W. der Van Graaf. "The diagnostic hurdle of an elderly male with bone pain: how 18F-FDG-PET led to diagnosis of a leiomyosarcoma of the adrenal gland", 2009. Abstract PMID
P. Laverman, S. Meeuwissen, S. van Berkel, W. Oyen, F. van Delft, F. Rutjes and O. Boerman. "In-depth evaluation of the cycloaddition--retro-Diels--Alder reaction for in vivo targeting with [(111)In]-DTPA-RGD conjugates", 2009. Abstract/PDF DOI PMID
P. Meijer, W. Oyen, D. Dekker, P. van den Broek, C. Wouters, O. Boerman, G. Scheffer, P. Smits and G. Rongen. "Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection", 2009. Abstract DOI PMID
W. Oyen and W. van der Graaf. "Molecular imaging of solid tumors: exploiting the potential", 2009. Abstract DOI PMID
D. Schinagl, A. Hoffmann, W. Vogel, J. van Dalen, S. Verstappen, W. Oyen and J. Kaanders. "Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?", 2009. Abstract/PDF DOI PMID
O. Schuurbiers, J. Kaanders, H. van der Heijden, R. Dekhuijzen, W. Oyen and J. Bussink. "The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer", 2009. Abstract DOI PMID
D. Schuurhuis, P. Verdijk, G. Schreibelt, E. Aarntzen, N. Scharenborg, A. de Boer, M. van de Rakt, M. Kerkhoff, M. Gerritsen, F. Eijckeler, J. Bonenkamp, W. Blokx, J. van Krieken, O. Boerman, W. Oyen, C. Punt, C. Figdor, G. Adema and I. de Vries. "In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients", 2009. Abstract DOI PMID
C. Sikkink, M. Reijnen, P. Laverman, W. Oyen and H. van Goor. "Tc-99m-PEG-liposomes target both adhesions and abscesses and their reduction by hyaluronate in rats with fecal peritonitis", 2009. Abstract/PDF DOI PMID
T. Stollman, T. Ruers, W. Oyen and O. Boerman. "New targeted probes for radioimaging of angiogenesis", 2009. Abstract/PDF DOI PMID
T. Stollman, M. Scheer, G. Franssen, K. Verrijp, W. Oyen, T. Ruers, W. Leenders and O. Boerman. "Tumor accumulation of radiolabeled bevacizumab due to targeting of cell- and matrix-associated VEGF-A isoforms", 2009. Abstract/PDF DOI PMID
E. Troost, J. Bussink, W. Oyen and J. Kaanders. "18F-FDG and 18F-FLT do not discriminate between reactive and metastatic lymph nodes in oral cancer", 2009. PDF DOI PMID
M. Truijers, J. Pol, H. Kurvers, S. Bredie, W. Oyen and J. Blankensteijn. "Incidental finding of malignancy in patients preoperatively evaluated for aneurysm wall pathology using PET/CT", 2009. Abstract/PDF DOI PMID
P. Verdijk, E. Aarntzen, W. Lesterhuis, A. Boullart, E. Kok, M. van Rossum, S. Strijk, F. Eijckeler, J. Bonenkamp, J. Jacobs, W. Blokx, J. Vankrieken, I. Joosten, O. Boerman, W. Oyen, G. Adema, C. Punt, C. Figdor and I. de Vries. "Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients", 2009. Abstract DOI PMID
E. Visser, J. Disselhorst, M. Brom, P. Laverman, M. Gotthardt, W. Oyen and O. Boerman. "Spatial resolution and sensitivity of the Inveon small-animal PET scanner", 2009. Abstract/PDF DOI PMID
D. Vriens, L. de Geus-Oei, W. van der Graaf and W. Oyen. "Tailoring therapy in colorectal cancer by PET-CT", 2009. Abstract PMID
D. Vriens, L. de Geus-Oei, H. van Laarhoven, J. Timmer-Bonte, P. Krabbe, E. Visser and W. Oyen. "Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studies", 2009. Abstract DOI PMID
D. Vriens, L. de Geus-Oei, W. Oyen and E. Visser. "A curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment", 2009. Abstract/PDF DOI PMID
S. Lütje, J. de Rooy, S. Croockewit, E. Koedam, W. Oyen and R. Raymakers. "Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma", 2009. Abstract/PDF DOI PMID
T. Ruers, B. Wiering, J. van der Sijp, R. Roumen, K. de Jong, E. Comans, J. Pruim, H. Dekker, P. Krabbe and W. Oyen. "Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study", 2009. Abstract/PDF DOI PMID
D. Vriens, H. van Laarhoven, J. van Asten, P. Krabbe, E. Visser, A. Heerschap, C. Punt, L. de Geus-Oei and W. Oyen. "Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate", 2009. Abstract/PDF DOI PMID

2008

Papers in international journals

F. Aarts, R. Bleichrodt, W. Oyen and O. Boerman. "Intracavitary radioimmunotherapy to treat solid tumors", 2008. Abstract/PDF DOI PMID
F. Aarts, T. Hendriks, O. Boerman, W. Oyen and R. Bleichrodt. "Hyperthermia and fibrinolytic therapy do not improve the beneficial effect of radioimmunotherapy following cytoreductive surgery in rats with peritoneal carcinomatosis of colorectal origin", 2008. Abstract/PDF DOI PMID
M. Binkowski, E. Tanck, M. Barink, W. Oyen, Z. Wrobel and N. Verdonschot. "Densitometry test of bone tissue: validation of computer simulation studies", 2008. Abstract/PDF DOI PMID
S. Bipat, M. van Leeuwen, W. Oyen, A. Planting, J. IJzermans and J. Stoker. "[Imaging in the diagnosis of colorectal liver metastases and extrahepatic abnormalities]", 2008. Abstract PMID
C. Bleeker-Rovers, F. Vos, F. Corstens and W. Oyen. "Imaging of infectious diseases using [18F] fluorodeoxyglucose PET", 2008. Abstract PMID
O. Boerman and W. Oyen. "Multimodality probes: amphibian cars for molecular imaging", 2008. PDF DOI PMID
A. Brouwers, P. Mulders and W. Oyen. "Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy", 2008. DOI PMID
L. de Geus-Oei, H. van Laarhoven, E. Visser, R. Hermsen, B. van Hoorn, Y. Kamm, P. Krabbe, F. Corstens, C. Punt and W. Oyen. "Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer", 2008. Abstract/PDF DOI PMID
L. Geus-Oei and W. Oyen. "Predictive and prognostic value of FDG-PET", 2008. Abstract DOI PMID
I. Krabbendam, B. Janssen, A. Van Dijk, H. Jongsma, W. Oyen, F. Lotgering and M. Spaanderman. "The relation between venous reserve capacity and low plasma volume", 2008. Abstract/PDF DOI PMID
P. Laverman, S. Roosenburg, M. Gotthardt, J. Park, W. Oyen, M. de Jong, M. Hellmich, F. Rutjes, F. van Delft and O. Boerman. "Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin", 2008. Abstract/PDF DOI PMID
M. Luster, S. Clarke, M. Dietlein, M. Lassmann, P. Lind, W. Oyen, J. Tennvall, E. Bombardieri and E. of (E. M). "Guidelines for radioiodine therapy of differentiated thyroid cancer", 2008. Abstract PMID
E. Oosterwijk, O. Boerman, W. Oyen, L. Old and P. Mulders. "Antibody therapy in renal cell carcinoma", 2008. Abstract/PDF DOI PMID
M. Scheer, T. Stollman, O. Boerman, K. Verrijp, F. Sweep, W. Leenders, T. Ruers and W. Oyen. "Imaging liver metastases of colorectal cancer patients with radiolabelled bevacizumab: Lack of correlation with VEGF-A expression", 2008. Abstract/PDF DOI PMID
M. Scheer, T. Stollman, W. Vogel, O. Boerman, W. Oyen and T. Ruers. "Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor", 2008. Abstract/PDF DOI PMID
A. Senft, R. de Bree, O. Hoekstra, D. Kuik, R. Golding, W. Oyen, J. Pruim, F. van den Hoogen, J. Roodenburg and C. Leemans. "Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial", 2008. Abstract/PDF DOI PMID
T. Stollman, M. Scheer, W. Leenders, K. Verrijp, A. Soede, W. Oyen, T. Ruers and O. Boerman. "Specific imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibody", 2008. Abstract DOI PMID
E. Troost, P. Laverman, M. Philippens, J. Lok, A. van der Kogel, W. Oyen, O. Boerman, J. Kaanders and J. Bussink. "Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts", 2008. Abstract/PDF DOI PMID
M. Versleijen, W. Oyen, H. Roelofs, S. van Emst-de Vries, P. Willems, J. Jansen and G. Wanten. "Immune function and leukocyte sequestration under the influence of parenteral lipid emulsions in healthy humans: a placebo-controlled crossover study", 2008. Abstract PMID
E. Visser, M. Philippens, L. Kienhorst, J. Kaanders, F. Corstens, L. de Geus-Oei and W. Oyen. "Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET", 2008. Abstract/PDF DOI PMID
M. Zuijdwijk, W. Vogel, F. Corstens and W. Oyen. "Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma", 2008. Abstract DOI PMID
R. Boellaard, W. Oyen, C. Hoekstra, O. Hoekstra, E. Visser, A. Willemsen, B. Arends, F. Verzijlbergen, J. Zijlstra, A. Paans, E. Comans and J. Pruim. "The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials", 2008. Abstract/PDF DOI PMID
C. van den den Bout-van Beukel, M. van den Bos, W. Oyen, A. Hermus, F. Sweep, C. Tack, M. Bosch, D. Burger, P. Koopmans and A. van der Ven. "The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients", 2008. Abstract DOI PMID
M. Chianelli, O. Boerman, G. Malviya, F. Galli, W. Oyen and A. Signore. "Receptor binding ligands to image infection", 2008. Abstract PMID
E. Troost, P. Laverman, J. Kaanders, W. Oyen, O. Boerman and J. Bussink. "Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-gluco-RGD autoradiography", 2008. PDF DOI PMID
M. Truijers, H. Kurvers, S. Bredie, W. Oyen and J. Blankensteijn. "In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall", 2008. Abstract/PDF DOI PMID
E. Vegt, J. van Eerd, A. Eek, W. Oyen, J. Wetzels, M. de Jong, F. Russel, R. Masereeuw, M. Gotthardt and O. Boerman. "Reducing renal uptake of radiolabeled peptides using albumin fragments", 2008. Abstract/PDF DOI PMID
B. Wiering, W. Vogel, T. Ruers and W. Oyen. "Controversies in the management of colorectal liver metastases: role of PET and PET/CT", 2008. Abstract/PDF DOI PMID
E. Cann, R. Koole, W. Oyen, J. de Rooy, P. de Wilde, P. Slootweg, M. Schipper, M. Merkx and P. Stoelinga. "Assessment of mandibular invasion of squamous cell carcinoma by various modes of imaging: constructing a diagnostic algorithm", 2008. Abstract/PDF DOI PMID
A. van de Luijtgaarden, J. de Rooy, L. de Geus-Oei, W. van der Graaf and W. Oyen. "Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice", 2008. Abstract/PDF DOI PMID
W. Vogel, D. Schinagl, J. Dalen, J. Kaanders and W. Oyen. "Validated image fusion of dedicated PET and CT for external beam radiation and therapy in the head and neck area", 2008. Abstract PMID

2007

Papers in international journals

F. Aarts, T. Hendriks, O. Boerman, M. Koppe, W. Oyen and R. Bleichrodt. "A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats", 2007. Abstract/PDF DOI PMID
F. Aarts, M. Koppe, T. Hendriks, J. van Eerd, W. Oyen, O. Boerman and R. Bleichrodt. "Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal origin", 2007. Abstract/PDF DOI PMID
H. Berger, S. van der Werf, C. Horstink, A. Cools, W. Oyen and M. Horstink. "Writer's cramp: restoration of striatal D2-binding after successful biofeedback-based sensorimotor training", 2007. Abstract/PDF DOI PMID
C. Bleeker-Rovers, H. Rennen, O. Boerman, A. Wymenga, E. Visser, J. Bakker, J. van der Meer, F. Corstens and W. Oyen. "99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation", 2007. Abstract PMID
C. Bleeker-Rovers, F. Vos, E. de Kleijn, A. Mudde, T. Dofferhoff, C. Richter, T. Smilde, P. Krabbe, W. Oyen and J. van der Meer. "A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol", 2007. Abstract DOI PMID
C. Bleeker-Rovers, F. Vos, A. Mudde, A. Dofferhoff, L. de Geus-Oei, A. Rijnders, P. Krabbe, F. Corstens, J. van der Meer and W. Oyen. "A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin", 2007. Abstract/PDF DOI PMID
O. Boerman, M. Koppe, E. Postema, F. Corstens and W. Oyen. "Radionuclide therapy of cancer with radiolabeled antibodies", 2007. Abstract PMID
B. Brans, L. Bodei, F. Giammarile, O. Linden, M. Luster, W. Oyen and J. Tennvall. "Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray"", 2007. Abstract/PDF DOI PMID
M. Cuijpers, F. Vos, C. Bleeker-Rovers, P. Krabbe, P. Pickkers, A. van Dijk, G. Wanten, P. Sturm, W. Oyen and B. Kullberg. "Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia", 2007. Abstract/PDF DOI PMID
J. van Dalen, E. Visser, W. Vogel, F. Corstens and W. Oyen. "Impact of Ge-68/Ga-68-based versus CT-based attenuation correction on PET", 2007. Abstract PMID
I. Dijkgraaf, O. Boerman, W. Oyen, F. Corstens and M. Gotthardt. "Development and application of peptide-based radiopharmaceuticals", 2007. Abstract PMID
I. Dijkgraaf, J. Kruijtzer, C. Frielink, F. Corstens, W. Oyen, R. Liskamp and O. Boerman. "Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide", 2007. Abstract DOI PMID
I. Dijkgraaf, J. Kruijtzer, S. Liu, A. Soede, W. Oyen, F. Corstens, R. Liskamp and O. Boerman. "Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides", 2007. Abstract DOI PMID
I. Dijkgraaf, S. Liu, J. Kruijtzer, A. Soede, W. Oyen, R. Liskamp, F. Corstens and O. Boerman. "Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide", 2007. Abstract/PDF DOI PMID
L. de Geus-Oei, H. van der Heijden, F. Corstens and W. Oyen. "Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review", 2007. Abstract DOI PMID
L. de Geus-Oei, H. van der Heijden, E. Visser, R. Hermsen, B. van Hoorn, J. Timmer-Bonte, A. Willemsen, J. Pruim, F. Corstens, P. Krabbe and W. Oyen. "Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer", 2007. Abstract/PDF DOI PMID
L. de Geus-Oei, J. van Krieken, R. Aliredjo, P. Krabbe, C. Frielink, A. Verhagen, O. Boerman and W. Oyen. "Biological correlates of FDG uptake in non-small cell lung cancer", 2007. Abstract DOI PMID
M. Gotthardt, J. van Eerd-Vismale, W. Oyen, M. de Jong, H. Zhang, E. Rolleman, H. Maecke, M. Béhé and O. Boerman. "Indication for different mechanisms of kidney uptake of radiolabeled peptides", 2007. Abstract PMID
C. Haaxma, B. Bloem, G. Borm, W. Oyen, K. Leenders, S. Eshuis, J. Booij, D. Dluzen and M. Horstink. "Gender differences in Parkinson's disease", 2007. Abstract DOI PMID
W. de Jong, H. van der Heijden, J. Pruim, O. Dalesio, W. Oyen and H. Groen. "Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study", 2007. Abstract DOI PMID
D. de Koning, J. Drenth, W. Oyen, M. Wagenaar, R. Aliredjo and F. Nagengast. "Pulmonary sclerosing hemangioma detected by fluorodeoxyglucose positron emission tomography in familial adenomatous polyposis: report of a case", 2007. Abstract DOI PMID
J. Kristinsson, W. Hopman, W. Oyen and J. Drenth. "Gastroparesis in patients with inactive Crohn's disease: a case series", 2007. Abstract/PDF DOI PMID
P. Laverman, W. Blokx, R. Te Morsche, C. Frielink, O. Boerman, W. Oyen and J. Drenth. "[(18)F]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma", 2007. Abstract DOI PMID
A. Oei, L. Massuger and W. Oyen. "Extraperitoneal leakage as a possible explanation for failure of one-time intraperitoneal treatment in ovarian cancer", 2007. Abstract DOI PMID
W. Oyen, L. Bodei, F. Giammarile, H. Maecke, J. Tennvall, M. Luster and B. Brans. "Targeted therapy in nuclear medicine--current status and future prospects", 2007. Abstract/PDF DOI PMID
H. Rennen, P. Laverman, J. van Eerd, W. Oyen, F. Corstens and O. Boerman. "PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation", 2007. Abstract/PDF DOI PMID
N. Riksen, B. Franke, W. Oyen, G. Borm, P. van den Broek, O. Boerman, P. Smits and G. Rongen. "Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene", 2007. Abstract/PDF DOI PMID
J. Ropela, L. van Die, W. Oyen and G. Rongen. "Fever and cough in a patient with diabetes. Empyema caused by S. typhimurium", 2007. PMID
A. Stillebroer, E. Oosterwijk, W. Oyen, P. Mulders and O. Boerman. "Radiolabeled antibodies in renal cell carcinoma", 2007. Abstract DOI PMID
E. Troost, W. Vogel, M. Merkx, P. Slootweg, H. Marres, W. Peeters, J. Bussink, A. van der Kogel, W. Oyen and J. Kaanders. "18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients", 2007. Abstract/PDF DOI PMID
C. Verstappen, B. Bloem, C. Haaxma, W. Oyen and M. Horstink. "Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study", 2007. Abstract DOI PMID
E. Visser, E. Postema, O. Boerman, J. Visschers, W. Oyen and F. Corstens. "Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND)", 2007. Abstract/PDF DOI PMID
W. Vogel, P. van Riel and W. Oyen. "FDG-PET/CT can visualise the extent of inflammation in rheumatoid arthritis of the tarsus", 2007. DOI PMID
B. Wiering, P. Krabbe, H. Dekker, W. Oyen and T. Ruers. "The role of FDG-PET in the selection of patients with colorectal liver metastases", 2007. Abstract/PDF DOI PMID
J. van Dalen, W. Vogel, F. Corstens and W. Oyen. "Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations", 2007. Abstract/PDF DOI PMID
T. Ruers, J. Joosten, B. Wiering, B. Langenhoff, H. Dekker, T. Wobbes, W. Oyen, P. Krabbe and C. Punt. "Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study", 2007. Abstract/PDF DOI PMID
D. Schinagl, W. Vogel, A. Hoffmann, J. van Dalen, W. Oyen and J. Kaanders. "Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer", 2007. Abstract/PDF DOI PMID
B. Wiering, T. Ruers, P. Krabbe, H. Dekker and W. Oyen. "Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery", 2007. Abstract/PDF DOI PMID
A. van der Eerden, M. den Heijer, W. Oyen and A. Hermus. "Cushing's syndrome and bone mineral density: lowest Z scores in young patients", 2007. Abstract/PDF PMID

2006

Papers in international journals

M. Koppe, W. Oyen, R. Bleichrodt, T. Hendriks, A. Verhofstad, D. Goldenberg and O. Boerman. "Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin", 2006. Abstract DOI PMID
E. Bastiaannet, O. Hoekstra, W. Oyen, P. Jager, T. Wobbes and H. Hoekstra. "Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases", 2006. Abstract DOI PMID
E. Bastiaannet, W. Oyen, S. Meijer, O. Hoekstra, T. Wobbes, P. Jager and H. Hoekstra. "Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients", 2006. Abstract DOI PMID
I. Dijkgraaf, J. Kruijtzer, C. Frielink, A. Soede, H. Hilbers, W. Oyen, F. Corstens, R. Liskamp and O. Boerman. "Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists", 2006. Abstract/PDF DOI PMID
J. van Eerd, L. de Geus-Oei, W. Oyen, F. Corstens and O. Boerman. "Scintigraphic imaging of P-glycoprotein expression with a radiolabelled antibody", 2006. Abstract DOI PMID
J. van Eerd, E. Vegt, J. Wetzels, F. Russel, R. Masereeuw, F. Corstens, W. Oyen and O. Boerman. "Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats", 2006. Abstract PMID
L. de Geus-Oei, B. Wiering, P. Krabbe, T. Ruers, C. Punt and W. Oyen. "FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma", 2006. Abstract DOI PMID
L. de Geus-Oei, J. Kaanders, L. Pop, F. Corstens and W. Oyen. "Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer", 2006. Abstract DOI PMID
L. de Geus-Oei, G. Pieters, J. Bonenkamp, A. Mudde, C. Bleeker-Rovers, F. Corstens and W. Oyen. "18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results", 2006. Abstract PMID
L. de Geus-Oei, T. Ruers, C. Punt, J. Leer, F. Corstens and W. Oyen. "FDG-PET in colorectal cancer", 2006. Abstract DOI PMID
L. de Geus-Oei, E. Visser, P. Krabbe, B. van Hoorn, E. Koenders, A. Willemsen, J. Pruim, F. Corstens and W. Oyen. "Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies", 2006. Abstract PMID
M. Gotthardt, M. Béhé, D. Beuter, A. Battmann, A. Bauhofer, T. Schurrat, M. Schipper, H. Pollum, W. Oyen and T. Behr. "Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma", 2006. Abstract DOI PMID
M. Gotthardt, M. Béhé, J. Grass, A. Bauhofer, A. Rinke, M. Schipper, M. Kalinowski, R. Arnold, W. Oyen and T. Behr. "Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours", 2006. Abstract DOI PMID
M. Gotthardt, I. Dijkgraaf, O. Boerman and W. Oyen. "Nuclear medicine imaging and therapy of neuroendocrine tumours", 2006. Abstract DOI PMID
M. Gotthardt, C. Rubner, A. Bauhofer, F. Berce, W. Oyen, J. Goecke, A. Pfestroff, A. Schlieck, F. Corstens, M. Béhé and T. Behr. "What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?", 2006. Abstract PMID
B. Hendrickx, C. Punt, O. Boerman, E. Postema, E. Oosterwijk, A. Mavridu, F. Corstens and W. Oyen. "Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250", 2006. Abstract DOI PMID
M. Koppe, O. Boerman, W. Oyen and R. Bleichrodt. "Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies", 2006. Abstract DOI PMID
M. Koppe, T. Hendriks, O. Boerman, W. Oyen and R. Bleichrodt. "Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis", 2006. Abstract PMID
M. Koppe, W. Oyen, R. Bleichrodt, A. Verhofstad, D. Goldenberg and O. Boerman. "Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin", 2006. Abstract/PDF DOI PMID
M. van Kouwen, J. Drenth, J. van Krieken, H. van Goor, P. Friederich, W. Oyen and F. Nagengast. "Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management", 2006. Abstract DOI PMID
M. van Kouwen, P. Laverman, J. van Krieken, W. Oyen, F. Nagengast and J. Drenth. "Noninvasive monitoring of colonic carcinogenesis: feasibility of [(18)F]FDG-PET in the azoxymethane model", 2006. Abstract DOI PMID
P. Laverman, I. de Vries, N. Scharenborg, A. de Boer, M. Broekema, W. Oyen, C. Figdor, G. Adema and O. Boerman. "Development of 111In-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination", 2006. Abstract DOI PMID
N. Riksen, Z. Zhou, W. Oyen, R. Jaspers, B. Ramakers, R. Brouwer, O. Boerman, N. Steinmetz, P. Smits and G. Rongen. "Caffeine prevents protection in two human models of ischemic preconditioning", 2006. Abstract DOI PMID
D. Scharn, W. Oyen, P. Klemm, A. Verhofstad and J. van der Vliet. "Thrombogenicity and related biological properties of heparin bonded collagen coated polyester and human umbilical vein prosthetic vascular grafts", 2006. Abstract DOI PMID
D. Schinagl, J. Kaanders and W. Oyen. "From anatomical to biological target volumes: the role of PET in radiation treatment planning", 2006. Abstract DOI PMID
E. Troost, P. Laverman, J. Kaanders, M. Philippens, J. Lok, W. Oyen, A. van der Kogel, O. Boerman and J. Bussink. "Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors", 2006. Abstract DOI PMID
E. Van Cann, W. Oyen, R. Koole and P. Stoelinga. "Bone SPECT reduces the number of unnecessary mandibular resections in patients with squamous cell carcinoma", 2006. Abstract DOI PMID
E. Vegt, J. Wetzels, F. Russel, R. Masereeuw, O. Boerman, J. van Eerd, F. Corstens and W. Oyen. "Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin", 2006. Abstract PMID
W. Vogel, J. van Dalen and W. Oyen. "Adequate evaluation of image registration in hybrid PET/CT", 2006. PMID
W. Vogel, J. van Dalen, D. Schinagl, J. Kaanders, H. Huisman, F. Corstens and W. Oyen. "Correction of an image size difference between positron emission tomography (PET) and computed tomography (CT) improves image fusion of dedicated PET and CT", 2006. Abstract PMID
F. Vos, C. Bleeker-Rovers, F. Corstens, B. Kullberg and W. Oyen. "FDG-PET for imaging of non-osseous infection and inflammation", 2006. Abstract PMID
F. Vos, C. Bleeker-Rovers, A. van Dijk and W. Oyen. "Detection of pacemaker and lead infection with FDG-PET", 2006. DOI PMID
B. Wensing, W. Vogel, H. Marres, M. Merkx, E. Postema, W. Oyen and F. van den Hoogen. "FDG-PET in the clinically negative neck in oral squamous cell carcinoma", 2006. Abstract DOI PMID

2005

Papers in international journals

C. Bleeker-Rovers, A. Warris, J. Drenth, F. Corstens, W. Oyen and B. Kullberg. "Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography", 2005. Abstract DOI PMID
M. Broekema, J. van Eerd, W. Oyen, F. Corstens, R. Liskamp, O. Boerman and T. Harris. "Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci", 2005. Abstract DOI PMID
A. Brouwers, W. Buijs, P. Mulders, P. de Mulder, W. van den Broek, C. Mala, E. Oosterwijk, O. Boerman, F. Corstens and W. Oyen. "Radioimmunotherapy with [131I]cG250 in patients with metastasized renal cell cancer: dosimetric analysis and immunologic response", 2005. Abstract DOI PMID
A. Brouwers, P. Mulders, P. de Mulder, W. van den Broek, W. Buijs, C. Mala, F. Joosten, E. Oosterwijk, O. Boerman, F. Corstens and W. Oyen. "Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma", 2005. Abstract DOI PMID
J. van Eerd, M. Broekema, T. Harris, D. Edwards, W. Oyen, F. Corstens and O. Boerman. "Imaging of infection and inflammation with an improved 99mTc-labeled LTB4 antagonist", 2005. Abstract PMID
J. van Eerd, W. Oyen, T. Harris, H. Rennen, D. Edwards, F. Corstens and O. Boerman. "Scintigraphic imaging of infectious foci with an 111In-LTB4 antagonist is based on in vivo labeling of granulocytes", 2005. Abstract PMID
M. de Groot, A. Meeuwis, P. Kok, F. Corstens and W. Oyen. "Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut", 2005. Abstract DOI PMID
P. Kok, J. van Eerd, O. Boerman, F. Corstens and W. Oyen. "Biodistribution and imaging of FDG in rats with LS174T carcinoma xenografts and focal Escherichia coli infection", 2005. Abstract DOI PMID
M. Koppe, R. Bleichrodt, W. Oyen and O. Boerman. "Radioimmunotherapy and colorectal cancer", 2005. Abstract DOI PMID
M. van Kouwen, J. Jansen, H. van Goor, S. de Castro, W. Oyen and J. Drenth. "FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis", 2005. Abstract DOI PMID
M. van Kouwen, P. Laverman, J. van Krieken, W. Oyen, J. Jansen and J. Drenth. "FDG-PET in the detection of early pancreatic cancer in a BOP hamster model", 2005. Abstract DOI PMID
M. van Kouwen, F. Nagengast, J. Jansen, W. Oyen and J. Drenth. "2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study", 2005. Abstract DOI PMID
H. van Laarhoven, L. de Geus-Oei, B. Wiering, J. Lok, M. Rijpkema, J. Kaanders, P. Krabbe, T. Ruers, C. Punt, A. van der Kogel, W. Oyen and A. Heerschap. "Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET", 2005. Abstract/PDF DOI PMID
M. Landheer, M. Steffens, J. Klinkenbijl, A. Westenberg and W. Oyen. "Value of fluorodeoxyglucose positron emission tomography in women with breast cancer", 2005. Abstract DOI PMID
W. Oyen, F. Corstens and O. Boerman. "Discriminating infection from sterile inflammation: can radiolabelled antibiotics solve the problem?", 2005. DOI PMID
C. Peeters, L. de Geus, J. Westphal, R. de Waal, D. Ruiter, T. Wobbes, W. Oyen and T. Ruers. "Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases", 2005. Abstract DOI PMID
N. Riksen, W. Oyen, B. Ramakers, P. den Van Broek, R. Engbersen, O. Boerman, P. Smits and G. Rongen. "Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans", 2005. Abstract DOI PMID
G. Rongen, W. Oyen, B. Ramakers, N. Riksen, O. Boerman, N. Steinmetz and P. Smits. "Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans", 2005. Abstract DOI PMID
F. van Schaijk, E. Oosterwijk, J. Molkenboer-Kuenen, A. Soede, B. McBride, D. Goldenberg, W. Oyen, F. Corstens and O. Boerman. "Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models", 2005. Abstract PMID
W. Vogel, B. Wensing, J. van Dalen, P. Krabbe, F. van den Hoogen and W. Oyen. "Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy", 2005. Abstract DOI PMID
C. Bleeker-Rovers, F. Vos, G. Wanten, J. van der Meer, F. Corstens, B. Kullberg and W. Oyen. "18F-FDG PET in detecting metastatic infectious disease", 2005. Abstract PMID
A. Brouwers, O. Boerman and W. Oyen. "In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer", 2005. DOI PMID
B. Hendrickx, C. van Herpen, J. Bonenkamp, J. Bulten and W. Oyen. "Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer. CASE 1. Mediastinal sarcoidosis in a melanoma patient treated with interferon", 2005. DOI PMID
K. Kösters, C. Bleeker-Rovers, R. van Crevel, W. Oyen and A. van der Ven. "Aortitis diagnosed by F-18-fluorodeoxyglucose positron emission tomography in a patient with syphilis and HIV coinfection", 2005. Abstract DOI PMID
M. Koppe, E. Postema, F. Aarts, W. Oyen, R. Bleichrodt and O. Boerman. "Antibody-guided radiation therapy of cancer", 2005. Abstract DOI PMID
E. Tan, W. Oyen and R. Goris. "Leukocytes in Complex Regional Pain Syndrome type I", 2005. Abstract/PDF DOI PMID
W. Vogel, B. Wiering, F. Corstens, T. Ruers and W. Oyen. "Colorectal cancer: the role of PET/CT in recurrence", 2005. Abstract DOI PMID
B. Wiering, P. Krabbe, G. Jager, W. Oyen and T. Ruers. "The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases", 2005. Abstract DOI PMID
I. de Vries, W. Lesterhuis, J. Barentsz, P. Verdijk, J. van Krieken, O. Boerman, W. Oyen, J. Bonenkamp, J. Boezeman, G. Adema, J. Bulte, T. Scheenen, C. Punt, A. Heerschap and C. Figdor. "Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy", 2005. Abstract/PDF DOI PMID

2004

Papers in international journals

H. Berger, A. Cools, M. Horstink, W. Oyen, E. Verhoeven and S. van der Werf. "Striatal dopamine and learning strategy-an (123)I-FP-CIT SPECT study", 2004. Abstract DOI PMID
C. Bleeker-Rovers, O. Boerman, H. Rennen, F. Corstens and W. Oyen. "Radiolabeled compounds in diagnosis of infectious and inflammatory disease", 2004. Abstract PMID
C. Bleeker-Rovers, F. Corstens, J. Der Van Meer and W. Oyen. "Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy", 2004. DOI PMID
C. Bleeker-Rovers, G. Jager, C. Tack, J. Der Van Meer and W. Oyen. "F-18-fluorodeoxyglucose positron emission tomography leading to a diagnosis of septic thrombophlebitis of the portal vein: description of a case history and review of the literature", 2004. Abstract PMID
C. Bleeker-Rovers, E. de Kleijn, F. Corstens, J. van der Meer and W. Oyen. "Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation", 2004. Abstract DOI PMID
C. Bleeker-Rovers, A. van der Ven, B. Zomer, L. de Geus-Oei, P. Smits, F. Corstens, P. Koopmans and W. Oyen. "F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients", 2004. PMID
A. Brouwers, P. Mulders, E. Oosterwijk, W. Buijs, F. Corstens, O. Boerman and W. Oyen. "Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies", 2004. Abstract DOI PMID
A. Brouwers, I. Verel, J. Van Eerd, G. Visser, M. Steffens, E. Oosterwijk, F. Corstens, W. Oyen, G. Van Dongen and O. Boerman. "PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats", 2004. Abstract DOI PMID
A. Brouwers, J. van Eerd, C. Frielink, E. Oosterwijk, W. Oyen, F. Corstens and O. Boerman. "Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re", 2004. Abstract PMID
J. van Eerd, P. Laverman, W. Oyen, T. Harris, D. Edwards, C. Ellars, F. Corstens and O. Boerman. "Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonist", 2004. Abstract PMID
L. de Geus-Oei, J. van Eerd-Vismale, C. Molthoff, F. Corstens, W. Oyen and O. Boerman. "Tracers to monitor the response to chemotherapy: in vitro screening of four radiopharmaceuticals", 2004. Abstract DOI PMID
M. Gotthardt, O. Boermann, T. Behr, M. Béhé and W. Oyen. "Development and clinical application of peptide-based radiopharmaceuticals", 2004. Abstract PMID
E. Hartman, J. Pikkemaat, J. Van Asten, J. Vehof, A. Heerschap, W. Oyen, P. Spauwen and J. Jansen. "Demineralized bone matrix-induced ectopic bone formation in rats: in vivo study with follow-up by magnetic resonance imaging, magnetic resonance angiography, and dual-energy X-ray absorptiometry", 2004. Abstract/PDF DOI PMID
M. Janssen, C. Frielink, I. Dijkgraaf, W. Oyen, D. Edwards, S. Liu, M. Rajopadhye, L. Massuger, F. Corstens and O. Boerman. "Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation", 2004. Abstract DOI PMID
M. Koppe, R. Bleichrodt, A. Soede, A. Verhofstad, D. Goldenberg, W. Oyen and O. Boerman. "Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin", 2004. Abstract PMID
M. van Kouwen, J. Drenth, W. Oyen, J. de Bruin, M. Ligtenberg, J. Bonenkamp, J. van Krieken and F. Nagengast. "[18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier", 2004. Abstract DOI PMID
M. van Kouwen, W. Oyen, F. Nagengast, J. Jansen and J. Drenth. "FDG-PET scanning in the diagnosis of gastrointestinal cancers", 2004. Abstract PMID
P. Laverman, M. Béhé, W. Oyen, P. Willems, F. Corstens, T. Behr and O. Boerman. "Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors", 2004. Abstract DOI PMID
W. Oyen, J. Bussink, A. Verhagen, F. Corstens and G. Bootsma. "Role of FDG-PET in the diagnosis and management of lung cancer", 2004. Abstract DOI PMID
H. Rennen, C. Bleeker-Rovers, J. van Eerd, C. Frielink, W. Oyen, F. Corstens and O. Boerman. "99mTc-labeled interleukin-8 for scintigraphic detection of pulmonary infections", 2004. Abstract DOI PMID
H. Rennen, C. Frielink, E. Brandt, S. Zaat, O. Boerman, W. Oyen and F. Corstens. "Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms", 2004. Abstract PMID
J. Spermon, W. Oyen, S. Strijk, C. de Hulsbergen-van Kaa and J. Witjes. "Solitary skull recurrence from stage I seminomatous germ cell tumor of testis", 2004. Abstract DOI PMID
A. Verhagen, E. Bollen, V. Tjan-Heijnen, G. Bootsma, A. Hensens and W. Oyen. "[The biopsying of at least 5 mediastinal lymph node stations for presurgical staging in patients with a non-small-cell lung carcinoma]", 2004. PMID
A. Verhagen, G. Bootsma, V. Tjan-Heijnen, G. van der Wilt, A. Cox, M. Brouwer, F. Corstens and W. Oyen. "FDG-PET in staging lung cancer: how does it change the algorithm?", 2004. Abstract DOI PMID
W. Vogel, W. Oyen, J. Barentsz, J. Kaanders and F. Corstens. "PET/CT: panacea, redundancy, or something in between?", 2004. Abstract PMID
B. Wiering, T. Ruers and W. Oyen. "Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases", 2004. Abstract DOI PMID

2003

Papers in international journals

P. Börjesson, E. Postema, J. Roos, D. Colnot, H. Marres, M. van Schie, G. Stehle, R. de Bree, G. Snow, W. Oyen and G. van Dongen. "Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma", 2003. Abstract PMID
P. Barrera, W. Oyen, O. Boerman and P. van Riel. "Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis", 2003. Abstract PMID
C. Bleeker-Rovers, S. Bredie, J. van der Meer, F. Corstens and W. Oyen. "F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis", 2003. Abstract PMID
C. Bleeker-Rovers, R. de Sévaux, H. van Hamersvelt, F. Corstens and W. Oyen. "Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease", 2003. Abstract PMID
O. Boerman, F. van Schaijk, W. Oyen and F. Corstens. "Pretargeted radioimmunotherapy of cancer: progress step by step", 2003. Abstract PMID
A. den Broeder, G. Wanten, W. Oyen, T. Naber, P. van Riel and P. Barrera. "Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis", 2003. Abstract PMID
A. Brouwers, W. Buijs, E. Oosterwijk, O. Boerman, C. Mala, P. De Mulder, F. Corstens, P. Mulders and W. Oyen. "Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison", 2003. Abstract PMID
A. Brouwers, C. Frielink, E. Oosterwijk, W. Oyen, F. Corstens and O. Boerman. "Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma", 2003. Abstract DOI PMID
F. Brouwers, W. Oyen, O. Boerman, J. Barrett, F. Verheugt, F. Corstens and J. der Van Meer. "Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis", 2003. Abstract DOI PMID
I. De Vries, D. Krooshoop, N. Scharenborg, W. Lesterhuis, J. Diepstra, G. Van Muijen, S. Strijk, T. Ruers, O. Boerman, W. Oyen, G. Adema, C. Punt and C. Figdor. "Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state", 2003. Abstract PMID
J. van Eerd, O. Boerman, F. Corstens and W. Oyen. "Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation", 2003. Abstract PMID
J. van Eerd, W. Oyen, T. Harris, H. Rennen, D. Edwards, S. Liu, C. Ellars, F. Corstens and O. Boerman. "A bivalent leukotriene B(4) antagonist for scintigraphic imaging of infectious foci", 2003. Abstract PMID
A. Eggert, R. van der Voort, R. Torensma, V. Moulin, O. Boerman, W. Oyen, C. Punt, H. Diepstra, A. de Boer, C. Figdor and G. Adema. "Analysis of dendritic cell trafficking using EGFP-transgenic mice", 2003. Abstract PMID
K. Havenga, D. Cobben, W. Oyen, S. Nienhuijs, H. Hoekstra, T. Ruers and T. Wobbes. "Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma", 2003. Abstract PMID
F. van den Hoogen and W. Oyen. "[Diagnostic image (149). A woman with a mass at the base of the tongue. Lingual thyroid]", 2003. Abstract PMID
E. Hoogendoorn, W. Oyen, A. van Dijk and J. van der Meer. "Pneumococcal aortitis, report of a case with emphasis on the contribution to diagnosis of positron emission tomography using fluorinated deoxyglucose", 2003. Abstract PMID
P. Jager, R. Slart, F. Corstens, W. Oyen, O. Hoekstra and J. Teule. "PET-CT: a matter of opinion?", 2003. DOI PMID
M. Janssen, W. Pels, L. Massuger, W. Oyen, H. Boonstra, F. Corstens and O. Boerman. "Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide", 2003. Abstract PMID
M. Koppe, A. Soede, W. Pels, W. Oyen, D. Goldenberg, R. Bleichrodt and O. Boerman. "Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin", 2003. Abstract DOI PMID
W. Oyen and L. Mansi. "FDG-PET in infectious and inflammatory disease", 2003. DOI PMID
E. Postema, P. Börjesson, W. Buijs, J. Roos, H. Marres, O. Boerman, R. de Bree, M. Lang, G. Munzert, G. van Dongen and W. Oyen. "Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer", 2003. Abstract PMID
E. Postema, W. Buijs, O. Boerman and W. Oyen. "Underestimation of absorbed dose to kidney", 2003. PMID
E. Postema, C. Frielink, W. Oyen, J. Raemaekers, D. Goldenberg, F. Corstens and O. Boerman. "Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma", 2003. Abstract DOI PMID
E. Postema, W. Oyen, O. Boerman and F. Corstens. "Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-labeled anti-CD20 monoclonal antibody", 2003. PMID
E. Postema, J. Raemaekers, W. Oyen, O. Boerman, C. Mandigers, D. Goldenberg, G. van Dongen and F. Corstens. "Final results of a phase I radioimmunotherapy trial using (186)Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma", 2003. Abstract PMID
H. Rennen, W. Oyen, S. Cain, P. Monk, F. Corstens and O. Boerman. "Tc-99m-labeled C5a and C5a des Arg74 for infection imaging", 2003. Abstract PMID
H. Rennen, O. Boerman, W. Oyen and F. Corstens. "Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection", 2003. Abstract PMID
F. van Schaijk, E. Oosterwijk, A. Soede, W. Oyen, W. McBride, G. Griffiths, D. Goldenberg, F. Corstens and O. Boerman. "Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re", 2003. Abstract PMID
N. Stikkelbroeck, W. Oyen, G. van der Wilt, A. Hermus and B. Otten. "Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia", 2003. Abstract DOI PMID
C. de Van Wiele, C. Lahorte, W. Oyen, O. Boerman, I. Goethals, G. Slegers and R. Dierckx. "Nuclear medicine imaging to predict response to radiotherapy: a review", 2003. Abstract PMID

2002

Papers in international journals

M. Becker, E. Dams, S. de Marie, W. Oyen, O. Boerman, M. Fens, H. Verbrugh and I. Bakker-Woudenberg. "Scintigraphic imaging using 99mTc-labeled PEG liposomes allows early detection of experimental invasive pulmonary aspergillosis in neutropenic rats", 2002. Abstract PMID
A. Brouwers, U. Dorr, O. Lang, O. Boerman, W. Oyen, M. Steffens, E. Oosterwijk, H. Mergenthaler, H. Bihl and F. Corstens. "131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study", 2002. Abstract PMID
S. Gratz, H. Rennen, O. Boerman, W. Oyen, P. Mast, T. Behr and F. Corstens. "99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection", 2002. Abstract PMID
M. Janssen, W. Oyen, L. Massuger, C. Frielink, I. Dijkgraaf, D. Edwards, M. Radjopadhye, F. Corstens and O. Boerman. "Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting", 2002. Abstract DOI PMID
M. Janssen, W. Oyen, I. Dijkgraaf, L. Massuger, C. Frielink, D. Edwards, M. Rajopadhye, H. Boonstra, F. Corstens and O. Boerman. "Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model", 2002. Abstract PMID
B. Langenhoff, W. Oyen, G. Jager, S. Strijk, T. Wobbes, F. Corstens and T. Ruers. "Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study", 2002. Abstract PMID
P. Laverman, O. Boerman, F. Corstens and W. Oyen. "Fluorinated amino acids for tumour imaging with positron emission tomography", 2002. Abstract DOI PMID
P. Laverman, O. Boerman, G. Storm and W. Oyen. "(99m)Tc-labelled Stealth liposomal doxorubicin (Caelyx) in glioblastomas and metastatic brain tumours", 2002. DOI PMID
H. Rennen, O. Boerman, W. Oyen and F. Corstens. "Labeling method largely affects the imaging potential of interleukin-8", 2002. PMID
H. Rennen, J. van Eerd, W. Oyen, F. Corstens, D. Edwards and O. Boerman. "Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection", 2002. Abstract PMID
T. Ruers, B. Langenhoff, N. Neeleman, G. Jager, S. Strijk, T. Wobbes, F. Corstens and W. Oyen. "Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study", 2002. Abstract PMID
D. Scharn, W. Oyen, P. Klemm, M. Wijnen and J. vanderVliet. "Assessment of prosthetic vascular graft thrombogenicity using the technetium-99m labeled glycoprotein IIb/IIIa receptor antagonist DMP444 in a dog model", 2002. Abstract PMID
J. Spermon, L. De Geus-Oei, L. Kiemeney, J. Witjes and W. Oyen. "The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours", 2002. Abstract PMID
M. Steffens, P. Mulders, A. Brouwers and W. Oyen. "Re: Clinical role of f-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma", 2002. DOI PMID
E. Strijks, M. van't Hof, F. Sweep, J. Lenders, W. Oyen and M. Horstink. "Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration", 2002. Abstract DOI PMID

1992

Other publications

W. Oyen. "Detection of infection and inflammation with indium-111 labeled human nonspecific immunoglobulin G", 1992. Abstract/PDF URL